§ 360e. Premarket approval

Legislative history

Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.

1. 1938

   Medical Device Amendments of 1976

   Pub. L. 94–295 § 2 · 90 Stat. 539

   Enacted · 21 U.S.C. § 360e

   June 25, 1938, ch. 675, § 515, as added Pub. L. 94–295, § 2, May 28, 1976, 90 Stat. 552

   Source evidence

   Code source credit
   June 25, 1938, ch. 675, § 515, as added Pub. L. 94–295, § 2, May 28, 1976, 90 Stat. 552

   Enacted provision · exact public law section
   Sec. 2. regulation of medical devices Chapter V is amended by adding after section 512 the following new sections: “classification of devices intended for human use “Sec. 513. “Device Classes (a) (1) There are established the following classes of devices intended for human use: “(A) Class I, General Controls.— “(i) A device for which the controls authorized by or under 21 USC 351, 352, 360. Post, pp. 560, 562, 564, 565. section 501, 502, 510, 516, 518, 519, or 520 or any combination of such sections are sufficient to provide reasonable assurance of the safety and effectiveness of the device. “(ii) A device for which insufficient information exists to determine that the controls referred to in clause (i) are sufficient to provide reasonable assurance of the safety and effectiveness of the device or to establish a performance standard to provide such assurance, but because it— “(I) is not purported or represented to be for a use in supporting or sustaining human life or for a use which is of substantial importance in preventing impairment of human health, and “(II) docs not present a potential unreasonable risk of illness or injury, is to be regulated by the controls referred to in clause (i). “(B) Class II, Performance Standards.— A device which cannot be classified as a class I device because the controls authorized by or under sections 501, 502, 510, 516, 518, 519, and 520 by themselves are insufficient to provide reasonable assurance 21 USC 351, 352, 360. Post, pp. 560, 562, 564, 565. of the safety and effectiveness of the device, for which there is sufficient information to establish a performance standard to provide such assurance, and for which it is therefore necessary to establish for the device a performance standard under section 514 to provide reasonable assurance of its safety and Post, p. 546. effectiveness. “(C) Class III, Premarket Approval.— A device which because— “(i) it (I) cannot be classified as a class I device because insufficient information exists to determine that the controls authorized by or under sections 501, 502, 510, 516, 518, 519, and 520 are sufficient to provide reasonable assurance of the safety and effectiveness of the device and (II) cannot be classified as a class II device because insufficient information exists for the establishment of a, performance standard to provide reasonable assurance of its safety and effectiveness, and “(ii) (I) is purported or represented to be for a use in supporting or sustaining human life or for a use which is of substantial importance in preventing impairment of human health, or “(II) presents a potential unreasonable risk of illness or injury, is to be subject, in accordance with section 515, to premarket Post, p. 552. approval to provide reasonable assurance of its safety and effectiveness. If there is not sufficient information to establish a performance standard for a device to provide reasonable assurance of its safety and effectiveness, the Secretary may conduct such activities as may be necessary to develop or obtain such information. “(2) For purposes of this section and sections 514 and 515, the safety and effectiveness of a device are to be determined— “(A) with respect to the persons for whose use the device is represented or intended, “(B) with respect to the conditions of use prescribed, recommended, or suggested in the labeling of the device, and “(C) weighing any probable benefit to health from the use of the device against any probable risk of injury or illness from such use. “(3) (A) Except as authorized by subparagraph (B), the effectiveness of a device is, for purposes of this section and sections 514 and 515, to be determined, in accordance with regulations promulgated by the Secretary, on the basis of well-controlled investigations, including clinical investigations where appropriate, by experts qualified by training and experience to evaluate the effectiveness of the device, from which investigations it can fairly and responsibly be concluded by qualified experts that the device will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling of the device. “(B) If the Secretary determines that there exists valid scientific evidence (other than evidence derived from investigations described in subparagraph (A))— “(i) which is sufficient to determine the effectiveness of a device, and “(ii) from which it can fairly and responsibly be concluded by qualified experts that the device will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling of the device, Post, pp. 546, 552. then, for purposes of this section and sections 514 and 515, the Secretary may authorize the effectiveness of the device to be determined on the basis of such evidence. “Classification; Classification Panels “(b) (1) For purposes of— “(A) determining which devices intended for human use should be subject to the requirements of general controls, performance standards, or premarket approval, and “(B) providing notice to the manufacturers and importers of such devices to enable them to prepare for the application of such requirements to devices manufactured or imported by them, the Secretary shall classify all such devices (other than devices classified by subsection (f)) into the classes established by subsection (a). Panels of experts. Establishment. For the purpose of securing recommendations with respect to the classification of devices, the Secretary shall establish panels of experts or use panels of experts established before the date of the enactment of this section, or both. Section 14 of the Federal Advisory 5 USC app. 1. Committee Act shall not apply to the duration of a panel established under this paragraph. “(2) The Secretary shall appoint to each panel established under paragraph (1) persons who are qualified by training and experience to evaluate the safety and effectiveness of the devices to be referred to the panel and who, to the extent feasible, possess skill in the use of, or experience in the development, manufacture, or utilization of, such devices. The Secretary shall make appointments to each panel so that each panel shall consist of members with adequately diversified expertise in such fields as clinical and administrative medicine, engineering, biological and physical sciences, and other related professions. Tn addition, each panel shall include as non voting members a representative of consumer interests and a representative of interests of the device manufacturing industry. Scientific, trade, and consumer organizations shall be afforded an opportunity to nominate individuals for appointment to the panels. No individual who is in the regular full-time employ of the United States and engaged in the administration of this Act may be a member of any panel. The Secretary shall designate one of the members of each panel to serve as chairman thereof. “(3) Panel members (other than officers or employees of the United States), while attending meetings or conferences of a panel or otherwise engaged in its business, shall be entitled to receive compensation at rates to be fixed by the Secretary, but not at rates exceeding the daily equivalent of the rate in effect for grade GS–18 of the General 5 USC 5332 note. Schedule, for each day so engaged, including traveltime; and while so serving away from their homes or regular places of business each member may be allowed travel expenses (including per diem in lieu of subsistence) as authorized by section 5703(b) of title 5, United States Code, for persons in the Government service employed intermittently. “(4) The Secretary shall furnish each panel with adequate clerical and other necessary assistance. “Classification Panel Organization and Operation “(c) (1) The Secretary shall organize the panels according to the various fields of clinical medicine and fundamental sciences in which devices intended for human use are used. The Secretary shall refer a device to be classified under this section to an appropriate panel established or authorized to be used under subsection (b) for its review and for its recommendation respecting the classification of the device. The Secretary shall by regulation prescribe the procedure to be followed by the panels in making their reviews and recommendations. In making their reviews of devices, the panels, to the maximum extent practicable, shall provide an opportunity for interested persons to submit data and views on the classification of the devices. “(2) (A) Upon completion of a panel’s review of a device referred to it under paragraph (1), the panel shall, subject to subparagraphs (B) and (C), submit to the Secretary its recommendation for the classification of the device. Any such recommendation shall (i) contain (I) a summary of the reasons for the recommendation, (II) a summary of the data upon which the recommendation is based, and (III) an identification of the risks to health (if any) presented by the device with respect to which the recommendation is made, and (ii) to the extent practicable, include a recommendation for the assignment of a priority for the application of the requirements of section 514 or 515 to a device recommended to be classified in class II or Post, pp. 546, 552. class III. “(B) A recommendation of a panel for the classification of a device in class I shall include a recommendation as to whether the device should be exempted from the requirements of section 510, 519, or 520(f). 21 USC 360. Post, pp. 564, 565. “(C) In the case of a device which has been referred under paragraph (1) to a panel, and which— “(i) is intended to be implanted in the human body or is purported or represented to be for a use in supporting or sustaining human life, and “(ii) (I) has been introduced or delivered for introduction into interstate commerce for commercial distribution before the date of enactment of this section, or “(II) is within a type of device which was so introduced or delivered before such date and is substantially equivalent to another device within that type, such panel shall recommend to the Secretary that the device be classified in class III unless the panel determines that classification of the device in such class is not necessary to provide reasonable assurance of its safety and effectiveness. If a panel does not recommend that such a device be classified in class III, it shall in its recommendation I o the Secretary for the classification of the device set forth the reasons for not recommending classification of the device in such class. “(3) The panels shall submit to the Secretary within one year of the date funds are first appropriated for the implementation of this section their recommendations respecting all devices of a type introduced or delivered for introduction into interstate commerce for commercial distribution before the date of the enactment of this section. “Classification “(d) (1) Upon receipt of a recommendation from a panel respecting a device, the Secretary shall publish in the Federal Register the panel’s recommendation and a proposed regulation classifying such device and shall provide interested persons an opportunity to submit comments on such recommendation and the proposed regulation. After reviewing such comments, the Secretary shall, subject to paragraph (2), by regulation classify such device. “(2) (A) A regulation under paragraph (1) classifying a device in class I shall prescribe which, if any, of the requirements of section 21 USC 360. Post, pp. 564, 565. 510, 519, or 520(f) shall not apply to the device. A regulation which makes a requirement of section 510, 519, or 520(f) inapplicable to a device shall be accompanied by a statement of the reasons of the Secretary for making such requirement inapplicable. “(B) A device described in subsection (c) (2) (C) shall be classified in class III unless the Secretary determines that classification of the device in such class is not necessary to provide reasonable assurance of its safety and effectiveness. A proposed regulation under paragraph (1) classifying such a device in a class other than class III shall be accompanied by a full statement of the reasons of the Secretary (and supporting documentation and data) for not classifying such device in such class and an identification of the risks to health (if any) presented by such device. “(3) In the case of devices classified in class II and devices classified under this subsection in class III and described in section 515(b) (1) the Secretary may establish priorities which, in his discretion, shall Post, p. 546. be used in applying sections 514 and 515, as appropriate, to such devices. “Classification Changes “(e) Based on new information respecting a device, the Secretary may, upon his own initiative or upon petition of an interested person, by regulation (1) change such device’s classification, and (2) revoke, because of the change in classification, any regulation or requirement in Publication in Federal Register. effect under section 514 or 515 with respect to such device. In the promulgation of such a regulation respecting a device’s classification, the Secretary may secure from the panel to which the device was last referred pursuant to subsection (c) a recommendation respecting the proposed change in the device’s classification and shall publish in the Federal Register any recommendation submitted to the Secretary by the panel respecting such change. A regulation under this subsection changing the classification of a device from class III to class II may provide that such classification shall not take effect until the effective date of a performance standard established under section 514 for such device. “Initial Classification of Certain Devices “(f) (1) Any device intended for human use which was not introduced or delivered for introduction into interstate commerce for commercial distribution before the date of the enactment of this section is classified in class III unless— “(A) the device— “(i) is within a type of device (I) which was introduced or delivered for introduction into interstate commerce for commercial distribution before such date and which is to be classified pursuant to subsection (b), or (II) which was not so introduced or delivered before such date and has been classified in class I or II, and “(ii) is substantially equivalent to another device within such type, or “(B) the Secretary in response to a petition submitted under paragraph (2) has classified such device in class I or II. A device classified in class III under this paragraph shall be classified in that class until the effective date of an order of the Secretary under paragraph (2) classifying the device in class I or II. “(2) (A) The manufacturer or importer of a device classified under Petition. paragraph (1) may petition the Secretary (in such form and manner as he shall prescribe) for the issuance of an order classifying the device in class I or class II. Within thirty days of the filing of such Notification. a petition, the Secretary shall notify the petitioner of any deficiencies in the petition which prevent the Secretary from making a decision on the petition. “(B) (i) Upon determining that a petition does not contain any deficiency which prevents the Secretary from making a decision on the petition, the Secretary shall refer the petition to an appropriate panel established or authorized to be used under subsection (b). A panel to which such a petition has been referred shall not later than ninety days after the referral of the petition make a recommendation to ti e Secretary respecting approval or denial of the petition. Any such recommendation shall contain (1) a summary of the reasons for the recommendation, (II) a summary of the data upon which the recommendation is based, and (III) an identification of the risks to health (if any) presented by the device with respect to which the petition was filed. In the case of a petition for a device which is intended to be implanted in the human body or which is purported or represented to be for a use in supporting or sustaining human life, the panel shall recommend that the petition be denied unless the panel determines that the classification in class III of the device is not necessary to provide reasonable assurance of its safety and effectiveness. If the panel recommends that such petition be approved, it shall in its recommendation to the Secretary set forth its reasons for such recommendation. “(ii) The requirements of paragraphs (1) and (2) of subsection (c) (relating to opportunities for submission of data and views and recommendations respecting priorities and exemptions from sections 510, 519, and 520(f) ) shall apply with respect to consideration by 21 USC 360. Post, pp. 564, 565. panels of petitions submitted under subparagraph (A). “(C) (i) Within ninety days from the date the Secretary receives the recommendation of a panel respecting a petition (but not later than 210 days after the filing of such petition) the Secretary shall by order deny or approve the petition. If the Secretary approves the petition, the Secretary shall order the classification of the device into class I or class II in accordance, with the criteria prescribed by subsection (a) (1) (A) or (a) (1) (B). In the case of a petition for a device which is intended to be implanted in the human body or which is purported or represented to be; for a use in supporting or sustaining human life, the Secretary shall deny the petition unless the Secretary determines that, the classification in class III of the device is not necessary to provide reasonable assurance of its safety and effectiveness. An order approving such petition shall be accompanied by a full statement of the reasons of the Secretary (and supporting documentation and data) for approving the petition and an identification of the risks to health (if any) presented by the device to which such order applies. “(ii) The requirements of paragraphs (1) and (2) (A) of subsec-tion (d) (relating to publication of recommendations, opportunity for submission of comments, and exemption from sections 510, 519, 21 USC 360. Post, pp. 564, 565. and 520(f)) shall apply with respect to action by the Secretary on petitions submitted under subparagraph (A). “Information “(g) Within sixty days of the receipt of a written request of any person for information respecting the class in which a device has been classified or the requirements applicable to a device under this Act, the Secretary shall provide such person a written statement of the classification (if any) of such device and the requirements of this Act applicable to the device. “Definitions “(h) For purposes of this section and sections 501, 510, 514, 515, 516, 519, and 520— “(1) a reference to ‘general controls’ is a reference to the controls authorized by or under sections 501, 502, 010, 516, 618, 519, and 520, “(2) a reference to ‘class I’, ‘class II’, or ‘class III’ is a reference to a class of medical devices described in subparagraph (A), (B), or (C) of subsection (a) (1), and “(3) a reference to a ‘panel under section 513’ is a reference to a panel established or authorized to be used under this section. “performance standards “Sec. 514. “Provisions of Standards (a) (1) The Secretary may by regulation, promulgated in accordance with this section, establish a performance standard for a class II device. A class III device may also be considered a class II device for purposes of establishing a standard for the device under this section i f the device has been reclassified as a class II device under a regulation under section 513(e) but such regulation provides that the reclassification is not to take effect until the effective date of such a standard for the device. “(2) A performance standard established under this section for a device— “(A) shall include provisions to provide reasonable assurance of its safe and effective performance; “(B) shall, where necessary to provide reasonable assurance of its safe and effective performance, include— “(i) provisions respecting the construction, components, ingredients, and properties of the device and its compatibility with power systems and connections to such systems, “(ii) provisions for the testing (on a sample basis or, if necessary, on an individual basis) of the device or, if it is determined that no other more practicable means are available to the Secretary to assure the conformity of the device to the standard, provisions for the testing (on a sample basis or, if necessary, on an individual basis) by the Secretary or by another person at the direction of the Secretary, “(iii) provisions for the measurement of the performance characteristics of the device, “(iv) provisions requiring that the results of each or of certain of the tests of the device required to be made under clause (ii) show that the device is in conformity with the portions of the standard for which the test or tests were required, and “(v) a provision requiring that the sale and distribution of the device be restricted hut only to the extent that the sale and distribution of a device may be restricted under a regulation under section 520(e); and Post, p. 565. Labeling. “(C) shall, where appropriate, require the use and prescribe the form and content of labeling for the proper installation, maintenance, operation, and use of the device. “(4) The Secretary shall provide for periodic evaluation of performance Periodic evaluation. standards established under this section to determine if such standards should be changed to reflect new medical, scientific, or other technological data. “(5) In carrying out his duties under this section, the Secretary shall, to the maximum extent practicable— “(A) use personnel, facilities, and other technical support available in other Federal agencies, “(B) consult with other Federal agencies concerned with standard-setting and other nationally or internationally recognized standard-setting entities, and “(C) invite appropriate participation, through joint or other conferences, workshops, or other means, by informed persons representative of scientific, professional, industry, or consumer organizations who in his judgment can make a significant contribution. “Initiation of a Proceeding for a Performance Standard “(b) (1) A proceeding for the development of a performance standard Publication in Federal Register. for a device shall be initiated by the Secretary by the publication in the Federal Register of notice or the opportunity to submit to the Secretary a request (within fifteen days of the date of the publication of the notice) for a change in the classification of the device based on new information relevant to its classification. “(2) If, after publication of a notice pursuant to paragraph (1) the Secretary receives a request for a change in the device’s classification, he shall, within sixty days of the publication of such notice and after consultation with the appropriate panel under section 513, by Ante, p. 540. order published in the Federal Register, either deny the request for change in classification or give notice of his intent to initiate such a change under section 513(e). “Invitation for Standards “(c) (1) If, after the publication of a notice under subsection (b), Publication in Federal Register. no action is required under paragraph (2) of such subsection or the Secretary denies a request to change the classification of the device with respect to which such notice was published, the Secretary shall publish in the Federal Register a notice inviting any person, including any Federal agency, to— “(A) submit to the Secretary, within sixty days after the date of publication of the notice, an existing standard as a proposed performance standard for such device, or “(B) offer, within sixty days after the date of publication of the notice, to develop such a proposed standard. “(2) A notice published pursuant to paragraph (1) for an offer for the development, of a proposed performance standard for a device— “(A) shall specify a period within which the standard is to be developed, which period may be extended by the Secretary for good cause shown; and “(B) shall include— “(i) a description or other designation of the device, “(ii) a statement of the nature of the risk or risks associated with the use of the device and intended to be controlled by a performance standard, “(iii) a summary of the data on which the Secretary has found a need for initiation of the proceeding to develop a performance standard, and “(iv) identification of any existing performance standard known to the Secretary which may be relevant to the proceeding. “(3) The Secretary shall by regulation require that an offeror of an offer to develop a proposed performance standard submit (and if the offeror is a business entity, require that appropriate directors, officers, and employees of, and consultants to, the business entity submit) to the Secretary such information concerning the offeror as the Secretary determines is relevant with respect to the offeror’s qualifications to develop a proposed performance standard for a device, including information respecting the offeror’s financial stability, expertise, and experience, and any potential conflicts of interest, including financial interest in the device for which the proposed standard is to be developed, current industrial or commercial affiliates of the offeror, current sources of financial support for research and business entities in which the offeror has a financial interest, which may be relevant with respect to the offeror’s qualifications. Such information submitted by an offeror may not be made public by the Secretary unless required by section 552 of title 5, United States Code, except that in the case of information submitted by an offeror whose offer has been accepted, the Secretary shall make such information (other than information which because of subsection (b)(4) of section 552, title 5, United States Code, is exempt from disclosure pursuant to subsection (a) of such section) public at the time the offer is accepted. “(4) If the Secretary determines that a performance standard can be developed by any Federal agency (including an agency within the Department of Health. Education, and Welfare), the Secretary may— “(A) if such determination is made with respect to an agency within such Department, develop such a standard in lieu of accepting any offer to develop such a standard pursuant to a notice published pursuant to this subsection, or “(B) if such determination is made with respect to any other agency, authorize such agency to develop such a standard in lieu of accepting any such offer. In making such a determination respecting a Federal agency, the Secretary shall take into account the personnel and expertise within such agency. The requirements described in subparagraphs (B) and (C) of subsection (e) (4) shall apply to development of a standard under this paragraph. “Acceptance of Certain Existing Standards “(d) (1) If the Secretary— “(A) determines that a performance standard has been issued or adopted or is being developed by any Federal agency or by any other qualified entity or receives a performance standard submitted pursuant to a notice published pursuant to subsection (c), and “(B) determines that such performance standard is based upon scientific data and information and has been subjected to scientific consideration, he may, in lieu of accepting any offer to develop such a standard pursuant to a notice published pursuant to subsection (c), accept such standard as a proposed performance standard for such device or as a basis upon which a proposed performance standard may be developed. “(2) If a standard is submitted to the Secretary pursuant to a notice Publication in Federal Register. published pursuant to subsection (c) and the Secretary does not accept such standard, he shall publish in the Federal Register notice of that fact together with the reasons therefor. “Acceptance of Offer To Develop Standard “(e) (1) Except as provided by subsections (c)(4) and (d), the Secretary shall accept one, and may accept more than one, offer to develop a proposed performance standard for a device pursuant to a notice published pursuant to subsection (c) if he determines that (A) the offeror is qualified to develop such a standard and is technically competent to undertake and complete the development of an appropriate performance standard within the period specified in the notice, and (B) the offeror will comply with procedures prescribed by regulations of the Secretary under paragraph (4) of this subsection. In determ filing the qualifications of an offeror to develop a standard, the Secretary shall take into account the offeror’s financial stability, expertise, experience, and any potential conflicts of interests (including financial interest in the device for which such standard is to be developed) and other information submitted pursuant to subsection (c) (3), which may be relevant with respect, to the offeror’s qualifications. “(2) The Secretary shall publish in the Federal Register the name Publication in Federal Register. and address of each person whose offer is accepted under paragraph (1) and a summary of the terms of such offer as accepted. “(3) If such an offer is accepted, the Secretary may, upon application which may be made prior to the acceptance of the offer, agree to contribute to the offeror’s cost in developing a proposed standard if the Secretary determines that such contribution is likely to result in a more satisfactory standard than would be developed without such contribution. The Secretary shall by regulation prescribe the items Regulation. of cost in which he will participate, except that such items may not include the cost of construction (except minor remodeling) or the acquisition of land or buildings. Payments to an offerer under this paragraph may be made without regard to section 3648 of the Revised Statutes (31 U.S.C. 529). “(4) The Secretary shall prescribe regulations governing the development Regulations. of proposed standards by persons whose offers are accepted under paragraph (1), Such regulations shall, notwithstanding subsection (b) (A) of section 553 of title 5, United States Code, be promulgated in accordance with the requirements of that section for not ice and opportunity for participation and shall— “(A) require that performance standards proposed for promulgation Performance standards. be supported by such test data or other documents or materials as the Secretary may reasonably require to be obtained; “(B) require that notice be given to interested persons of the Notice. opportunity to participate in the development of such performance standards and require the provision of such opportunity; “(C) require the maintenance of records to disclose (i) the Record maintenance. course of the development of performance standards proposed for promulgation, (ii) the comments and other information sub-nutted by any person in connection with such development, including comments and information with respect, to the need for such performance standards, and (iii) such other matters as may be relevant to the evaluation of such performance standards; “(D) provide that the Secretary and the Comptroller General of the United States, or any of their duly authorized representatives, shall have access for the purpose of audit and examination to any books, documents, papers, and other records, relevant to the expenditure of any funds contributed by the Secretary under paragraph (3); and “(E) require the submission of such periodic reports as the Secretary may require to disclose the course of the development of performance standards proposed for promulgation. “(5) If an offer is made pursuant to a notice published pursuant to subsection (c) and the Secretary does not accept such offer, he shall publish in the Federal Register notice of that fact together with the reasons therefor. “Development of Standard by Secretary After Publication of Subsection (c) Notice “(f) If the Secretary has published a notice pursuant to subsection (c) and— “(1) no person makes an offer or submits a standard pursuant to the notice; “(2) the Secretary has not accepted an existing performance standard under subsection (d) or accepted an offer to develop a proposed performance standard pursuant to the notice; or “(3) the Secretary has accepted an offer or offers to develop a proposed performance standard, but determines thereafter that— “(A) the offeror under each such offer is unwilling or unable to continue the development of the performance standard which was the subject of the offer or offers, or “(B) the performance standard which has been developed is not satisfactory, Publication in Federal Register. and publishes notice of that determination in the Federal Register together with his reasons therefor; then the Secretary may proceed to develop a proposed performance standard. The authority provided by this subsection is in addition to the authority provided by subsection (c)(4). The requirements described in subparagraphs (B) and (C) of subsection (e) (4) shall apply t° Hie development of a standard by the Secretary under this subsection. “Establishment of a Standard “(g) (1) (A) After publication pursuant to subsection (c) of a notice respecting a performance standard for a device, the Secretary shall either— “(i) publish, in the Federal Register in a notice of proposed rulemaking, a proposed performance standard for the device (I) developed by an offeror under such notice and accepted by the Secretary, (H) developed under subsection (c)(4), (HI) accepted by the Secretary under subsection (d), or (IV) developed by him under subsection (f), or “(ii) issue a notice in the Federal Register that the proceeding is terminated together with the reasons for such termination. “(B) If the Secretary issues under subparagraph (A)(ii) a notice of termination of a proceeding to establish a performance standard for a device, he shall (unless such notice is issued because the device is a banned device under section 516) initiate a proceeding under Post, p. 560. Ante, p, 540. section 513(e) to reclassify the device subject to the proceeding terminated by such notice. “(2) A notice of proposed rulemaking for the establishment of a Notice of proposed rulemaking. performance standard for a device published under paragraph (1) (A) (i) shall set forth proposed findings with respect to the degree of the risk of illness or injury designed to be eliminated or reduced by the proposed standard and the benefit to the public from the device. “(3) (A) After the expiration of the period for comment on a notice Publication in Federal Register. of proposed rulemaking published under paragraph (1) respecting a performance standard and after consideration of such comments and any report from an advisory committee under paragraph (5), the Secretary shall (i) promulgate a regulation establishing a performance standard and publish in the Federal Register findings on the matters referred to in paragraph (2), or (ii) publish a notice terminating the Notice. proceeding for the development of the standard together with the reasons for such termination. If a notice of termination is published, the Secretary shall (unless such notice is issued because the device is a banned device under section 516) initiate a proceeding under Section 513(e) to reclassify the device subject to the proceeding terminated by such notice. “(B) A regulation establishing a performance standard shall set forth the date or dates upon which the standard shall take effect, but no such regulation may take effect before one year after the date of its publication unless (i) the Secretary determines that an earlier effective date is necessary for the protection of the public health and safety, or (ii) such standard has been established for a device which, effective upon the effective date of the standard, has been reclassified from class III to class II, Such date or dates shall be established so as to minimize, consistent with the public health and safety, economic loss to, and disruption or dislocation of, domestic and international trade. “(4) (A) The Secretary, upon his own initiative or upon petition of Regulation. an interested person may by regulation, promulgated in accordance with the requirements of paragraphs (2) and (3) (B) of this subsection amend or revoke a performance standard. “(B) The Secretary may declare a proposed amendment of a performance standard to be effective on and after its publication in the Federal Register and until the effective date of any final action taken on such amendment if he determines, after affording all interested persons an opportunity for an informal hearing, that making it so effective is in the public interest. A proposed amendment of a performance standard made so effective under the preceding sentence may not prohibit, during the period in which it is so effective, the introduction or delivery for introduction into interstate commerce of a device which conforms to such standard without the change or changes provided by such proposed amendment. “(5) (A) The Secretary— “(i) may on his own initiative refer a proposed regulation for the establishment, amendment, or revocation of a performance standard, or “(ii) shall, upon the request of an interested person unless the Secretary finds the request to be without good cause or the request is made after the expiration of the period for submission of comments on such proposed regulation refer such proposed regulation, to an advisory committee of experts, established pursuant to subpara-graph (B), for a report anti recommendation with respect to any matter involved in the proposed regulation which requires the exercise of scientific judgment. If a proposed regulation is referred under this subparagraph to an advisory committee, the Secretary shall provide the advisory committee with the data and information on which such proposed regulation is based. The advisory committee shall, within Report and recommendation. sixty days of the referral of a proposed regulation and after independent study of the data and information furnished to it by the Secretary and other data and information before it, submit to the Secretary a report and recommendation respecting such regulation, together with all underlying data and information and a statement Information, availability to public. Advisory committees. Ante, p. 540. of the reason or basis for the recommendation. A copy of such report and recommendation shall be made public by the Secretary. “(B) The Secretary shall establish advisory committees (which may not be panels under section 513) to receive referrals under subparagraph (A). The Secretary shall appoint as members of any such advisory committee, persons qualified in the subject matter to be referred to the committee and of appropriately diversified professional background, except that the Secretary may not appoint to such a committee any individual who is in the regular full-time employ of the United States and engaged in the administration of this Act, Each such committee shall include as non voting members a representative of consumer interests and a representative of interests of the device manufacturing industry. Members of an advisory committee who are not officers or employees of the United States, while attending conferences or meetings of their committee or otherwise serving at the request of the Secretary, shall be entitled to receive compensation at rates to be fixed by the Secretary, which rates may not exceed the daily equivalent of the rate in effect for grade GS–18 5 USC 5332 note. of the General Schedule, for each day (including traveltime) they are so engaged; and while so serving away from their homes or regular places of business each member may be allowed travel expenses, including per diem in lieu of subsistence, as authorized by section 5703 of title 5 of the United States Code for persons in the Government service employed intermittently. The Secretary shall designate one of the members of each advisory committee to serve as chairman Procedures, regulation. thereof. The Secretary shall furnish each advisory committee with clerical and other assistance, and shall by regulation prescribe the procedures to be followed by each such committee in acting on referrals made under subparagraph (A). “premarket approval “Sec. 515. “General Requirement (a) A class III device— “(1) which is subject to a regulation promulgated under subsection (b); or “(2) which is a class III device because of section 513(f), Post, p. 565. is required to have, unless exempt under section 520(g), an approval under this section of an application for premarket approval. “Regulation To Require Premarket Approval “(b) (1) In the case of a class III device which— “(A) was introduced or delivered for introduction into inter-state commerce for commercial distribution before the date of enactment of this section; or “(B) is (i) of a type so introduced or delivered, and (ii) is substantially equivalent to another device within that type, the Secretary shall by regulation, promulgated in accordance with this subsection, require that such device have an approval under this section of an application for premarket approval. “(2) (A) A proceeding for tile promulgation of a regulation under Publication in Federal Register. paragraph (1) respecting a device shall be initiated by the publication in the Federal Register of a notice of proposed rulemaking. Such notice shall contain— “(i) the proposed regulation; “(ii) proposed findings with respect to the degree of risk of illness or injury designed to be eliminated or reduced by requiring the device to have an approved application for premarket approval and the benefit to the public from use of the device; “(iii) opportunity for the submission of comments on the proposed regulation and the proposed findings; and “(iv) opportunity to request a change in the classification of the device based on new information relevant to the classification of the device. “(B) If, within fifteen days after publication of a notice under subparagraph Publication in Federal Register. (A), the Secretary receives a request for a change in the classification of a device, he shall, within sixty days of the publication of such notice and after consultation with the appropriate panel under section 513, by order published in the Federal Register, either deny the Ante, p. 540. request for change in classification or give notice of his intent to initiate such a change under section 513(e), “(3) After the expiration of the period for comment on a proposed Publication in Federal Register. regulation and proposed findings published under paragraph (2) and after consideration of comments submitted on such proposed regulation and findings, the Secretary shall (A) promulgate such regulation and publish in the Federal Register findings on the matters referred to in paragraph (2) (A) (ii), or (B) publish a notice terminating the proceeding for the promulgation of the regulation together with the reasons for such termination. If a notice of termination is published, the Secretary shall (unless such notice is issued because the device is a banned device under section 516) initiate a proceeding Post, p, 560, under section 513(e) to reclassify the device subject to the proceeding terminated by such notice. “(4) The Secretary, upon his own initiative or upon petition of an interested person, may by regulation amend or revoke any regulation promulgated under this subsection. A regulation to amend or revoke a regulation under this subsection shall be promulgated in accordance with the requirements prescribed by this subsection for the promulgation of the regulation to be amended or revoked. “Application for Premarket Approval “(c) (1) Any person may file with the Secretary an application for premarket approval for a class III device. Such an application for a device shall contain— “(A) full reports of all information, published or known to or which should reasonably be known to the applicant, concerning investigations which have been made to snow whether or not such device is safe and effective; “(B) a full statement of the components, ingredients, and properties and of the principle or principles of operation, of such device; “(C) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and, when relevant, packing and installation of, such device; “(D) an identifying reference to any performance standard Ante, p. 546. under section 514 which would be applicable to any aspect of such device if it were a class II device, and either adequate information to show that such aspect of such device fully meets such performance standard or adequate information to justify any deviation from such standard: “(E) such samples of such device and of components thereof as the Secretary may reasonably require, except that where the sub-mission of such samples is impracticable or unduly burdensome, the requirement of this subparagraph may be met by the sub-mission of complete information concerning the location of one or more such devices readily available for examination and testing; “(F) specimens of the labeling proposed to be used for such device; and “(G) such other information relevant to the subject matter of the application as the Secretary, with the concurrence of the Ante, p. 540. appropriate panel under section 513, may require. “(2) Upon receipt of an application meeting the requirements set forth in paragraph (1), the Secretary shall refer such application to the appropriate panel under section 513 for study and for submission (within such period as he may establish) of a report and recommendation respecting approval of the application, together with all underlyingdata and the reasons or basis for the recommendation. “Action on an Application for Premarket Approval “(d) (1) (A) As promptly as possible, but in no event later than one hundred and eighty days after the receipt of an application under Post, p. 565. subsection (c) (except as provided in section 520(1) (3) (D) (ii) or unless, in accordance with subparagraph (B) (i), an additional period as agreed upon by the Secretary and the applicant), the Secretary, after considering the report and recommendation submitted under paragraph (2) of such subsection, shall— “(i) issue an order approving the application if he finds that none of the grounds for denying approval specified in paragraph (2) of this subsection applies; or “(ii) deny approval of the application if he finds (and sets forth the basis for such finding as part, of or accompanying such denial) that one or more grounds for denial specified in paragraph (2) of this subsection apply. “(B) (i) The Secretary may not enter into an agreement to extend the period in which to take action with respect to an application submitted for a device, subject to a regulation promulgated under subsection (b) unless he finds that, the continued availability of the device is necessary for the public health. “(ii) An order approving an application for a device may require as a condition to such approval that the sale and distribution of the device be restricted but only to the extent that the sale and distribution of a device may be restricted under a regulation under section 520(e). “(2) The Secretary shall deny approval of an application for a device if, upon the basis of the information submitted to the Secretary as part of the application and any other information before him with respect to such device, the Secretary finds that— “(A) there is a lack of a showing of reasonable assurance that such device is safe under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; “(B) there is a lack of a showing of reasonable assurance that the device is effective under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; “(C) the methods used in, or the facilities or controls used for, the manufacture, processing, packing, or installation of such device do not conform to the requirements of section 520(f); Post, p. 565. “(D) based on a fair evaluation of all material facts, the proposed labeling is false or misleading in any particular; or “(E) such device is not shown to conform in all respects to a performance standard in effect under section 514 compliance with Ante, p. 546. which is a condition to approval of the application and there is a lack of adequate information to justify the deviation from such standard. Any denial of an application shall, insofar as the Secretary determines Statement. to be practicable, be accompanied by a statement informing the applicant of the measures required to place such application in approvable form (which measures may include further research by the applicant in accordance with one or more protocols prescribed by the Secretary). “(3) An applicant whose application has been denied approval may, Review. by petition filed on or before the thirtieth day after the date upon which he receives notice of such denial, obtain review thereof in accordance with either paragraph (1) or (2) of subsection (g), and any interested person may obtain review, in accordance with paragraph (1) or (2) of subjection (g), of an order of the Secretary approving an application. “Withdrawal of Approval of Application “(e) (1) The Secretary shall, upon obtaining, where appropriate, Notice and hearing. Ante, p. 540. advice on scientific matters from a panel or panels under section 513, and after due notice and opportunity for informal hearing to the holder of an approved application for a device, issue an order withdrawing approval of the application if the Secretary finds— “(A) that such device is unsafe or ineffective under the conditions of use prescribed, recommended, or suggested in the labeling thereof; “(B) on the basis of new information before Id in with respect to such device, evaluated together with the evidence available to him when the application was approved, that there is a lack of a showing of reasonable assurance that the device is safe or effective under the conditions of use prescribed, recommended, or suggested in the labeling thereof; “(C) that the application contained or was accompanied by an untrue statement of a material fact; “(D) that the applicant (i) has failed to establish a system Record maintenance. for maintaining records, or has repeatedly or deliberately failed to maintain records or to make reports, required by an applicable regulation under section 519(a), (ii) has refused to permit access Post, p. 564. to, or copying or verification of, such records as required by section 704, or (iii) has not complied with the requirements of 21 USC 374. 21 USC 360. section 510; “(E) on the basis of new information before him with respect to such device, evaluated together with the evidence before him when the application was approved, that the methods used in, or the facilities and controls used for, the manufacture, processing, packing, or installation of such device do not conform with the requirements of section 520(f) and were not brought into conformity with such Post, p. 565. requirements within a reasonable time after receipt of written notice from the Secretary of nonconformity; “(F) on the basis of new information before him, evaluated together with the evidence before him when the application was approved, that the labeling of such device, based on a fair evaluation of all material facts, is false or misleading in any particular and was not corrected within a reasonable time after receipt of written notice from the Secretary of such fact; or “(G) on the basis of new information before him, evaluated together with the evidence before him when the application was approved, that such device is not shown to conform in all respects Ante, p. 546. to a performance standard which is in effect under section 514 compliance with which was a condition to approval of the application and that there is a lack of adequate information to justify the deviation from such standard. “(2) The holder of an application subject to an order issued under paragraph (1) withdrawing approval of the application may, by petition filed on or before the thirtieth day after the date upon which he receives notice of such withdrawal, obtain review thereof in accordance with either paragraph (1) or (2) of subsection (g). “Product Development Protocol “(f) (1) In the case of a class III device which is required to have an approval of an application submitted under subsection (c), such device shall be considered as having such an approval if a notice of completion of testing conducted in accordance with a product development protocol approved under paragraph (4) has been declared completed under paragraph (6). “(2) Any person may submit to the Secretary a proposed product development protocol with respect to a device. Such a protocol shall be accompanied by data supporting it. If, within thirty days of the receipt of such a protocol, the Secretary determines that it appears to be appropriate to apply the requirements of this subsection to the device with respect to which the protocol is submitted, he shall refer Ante, p. 540. the proposed protocol to the appropriate panel under section 513 for its recommendation respecting approval of the protocol. “(3) A proposed product development protocol for a device may be approved only if— “(A) the Secretary determines that it is appropriate to apply the requirements of this subsection to the device in lieu of the requirement of approval of an application submitted under subsection (c); and “(B) the Secretary determines that the proposed protocol provides— “(i) a description of the device and the change« which may be made in the device, “(ii) a description of the preclinical trials (if any) of the device and a specification of (I) the results from such trials to be required before the commencement of clinical trials of the device, and (II) any permissible variations in preclinical trials and the results therefrom, “(iii) a description of the clinical trials (if any) of the device and a specification of (I) the results from such trials to be required before the filing of a notice of completion of the requirements of the protocol, and (II) any permissible variations in such trials and the results therefrom, “(iv) a description of the methods to be used in, and the facilities and controls to be used for, the manufacture, processing, and, when relevant, packing and installation of the device, “(v) an identifying reference to any performance standard under section 514 to be applicable to any aspect of such device, Ante, p. 546. “(vi) if appropriate, specimens of the labeling proposed to be used for such device, “(vii) such other information relevant to the subject matter of the protocol as the Secretary, with the concurrence of the appropriate panel or panels under section 513, may require, Ante, p. 540. and “(viii) a requirement for submission of progress reports Progress report. and, when completed, records of the trials conducted under the protocol which records are adequate to show compliance with the protocol. “(4) The Secretary shall approve or disapprove a proposed product development protocol submitted under paragraph (2) within one hundred and twenty days of its receipt unless an additional period is agreed upon by the Secretary and the person who submitted the protocol. Approval of a protocol or denial of approval of a protocol is final agency action subject to judicial review under chapter 7 of title 5, United States Code. 5 USC 701 et seq. Notice of completion. “(5) At any time after a product development protocol for a device has been approved pursuant to paragraph (4), the person for whom the protocol was approved may submit a notice of completion— “(A) stating (i) his determination that the requirements of the protocol have been fulfilled and that, to the best of his knowledge, there is no reason bearing on safety or effectiveness why the notice of completion should not become effective, and (ii) the data and other information upon which such determination was made, and “(B) setting forth the results of the trials required by the protocol and all the information required by subsection (c) (1). “(6) (A) The Secretary may, after providing the person who has Final order to revoke protocol. an approved protocol an opportunity for an informal hearing and at any time prior to receipt of notice of completion of such protocol, issue a final order to revoke such protocol if he finds that— “(i) such person has failed substantially to comply with the requirements of the protocol, “(ii) the results of the trials obtained under the protocol differ so substantially from the results required by the protocol that further trials cannot be justified, or “(iii) the results of the trials conducted under the protocol or available new information do not demonstrate that the device tested under the protocol does not present an unreasonable risk to health and safety. “(B) After the receipt of a notice of completion of an approved protocol the Secretary shall, within the ninety-day period beginning on the date such notice is received, by order either declare the protocol completed or declare it not completed. An order declaring a protocol not completed may take effect only after the Secretary has provided the person who has the protocol opportunity for an informal nearing on the order. Such an order may be issued only if the Secretary finds— “(i) such person has failed substantially to comply with the requirements of the protocol, “(ii) the results of the trials obtained under the protocol differ substantially from the results required by the protocol, or “(iii) there is a lack of a showing of reasonable assurance of the safety and effectiveness of the device under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof. “(C) A final order issued under subparagraph (A) or (B) shall be in writing and shall contain the reasons to support the conclusions thereof. “(7) At any time after a notice of completion has become effective, the Secretary may issue an order (after due notice and opportunity for an informal hearing to the person for whom the notice is effective) revoking the approval of a device provided by a notice of completion which has become effective as provided in subparagraph (B) if he finds that any of the grounds listed in subparagraphs (A) through (G) of subsection (e) (1) of this section apply. Each reference in such subparagraphs to an application shall be considered for purposes of this paragraph as a reference to a protocol and the notice of completion of such protocol, and each reference to the time when an application was approved shall be considered for purposes of this paragraph as a reference to the time when a notice of completion took effect. “(8) A person who has an approved protocol subject to an order issued under paragraph (6) (A) revoking such protocol, a person who has an approved protocol with respect to which an order under paragraph (6)(B) was issued declaring that the protocol had not been completed, or a person subject to an order issued under paragraph (7) revoking the approval of a device may, by petition filed on or before the thirtieth day after the date upon which he receives notice of such order, obtain review thereof in accordance with either paragraph (1) or (2) of subsection (g). “Review “(g) (1) Upon petition for review of— “(A) an order under subsection (d) approving or denying approval of an application or an order under subsection (e) with-drawing approval of an application, or “(B) an order under subsection (f)(6)(A) revoking an approved protocol, under subsection (f)(6)(B) declaring that an approved protocol has not been completed, or under subsection (f) (7) revoking the approval of a device, the Secretary shall, unless he finds the petition to be without good cause or unless a petition for review of such order has been submitted under paragraph (2), hold a hearing, in accordance with section 554 of title 5 of the United States Code, on the order. The panel or panels which considered the application, protocol, or device subject to such order shall designate a member to appear and testify at any such hearing upon request of the Secretary, the petitioner, or the officer conducting the hearing, but this requirement does not preclude any other member of the panel or panels from appearing and testifying at any Order. such hearing. Upon completion of such hearing and after considering the record established in such hearing, the Secretary shall issue an order either affirming the order subject to the hearing or reversing such order and, as appropriate, approving or denying approval of the application, reinstating the application’s approval, approving the protocol, or placing in effect a notice of completion. “(2) (A) Upon petition for review of— “(i) an order under subsection (d) approving or denying approval of an application or an order under subsection (e) withdrawing approval of an application, or “(ii) an order under subsection (f)(6)(A) revoking an approved protocol, under subsection (f)(6)(B) declaring that an approved protocol has not been completed, or under subsection (f) (7) revoking the approval of a device, the Secretary shall refer the application or protocol subject to the order and the basis for the order to an advisory committee of experts established pursuant to subparagraph (B) for a report and recommendation with respect to the order. The advisory committee Report and recommendation. shall, after independent study of the data and information furnished to it by the Secretary and other data and information before it, submit to the Secretary a report and recommendation, together with all under-lying data and information and a statement of the reasons or basis for the recommendation. A copy of such report shall be promptly supplied by the Secretary to any person who petitioned for such referral to the advisory committee. “(B) The Secretary shall establish advisory committees (which may Advisory committees. Establishment. not be panels under section 513) to receive referrals under subparagraph (A). The Secretary shall appoint as members of any such advisory committee persons qualified in the subject matter to be referred to the committee and of appropriately diversified professional backgrounds, except that the Secretary may not appoint to such a committee any individual who is in the regular full-time employ of the United States and engaged in the administration of this Act. Members of an advisory committee (other than officers or employees Compensation. of the United States), while attending conferences or meetings of their committee or otherwise serving at the request of the Secretary, shall be entitled to receive compensation at rates to be fixed by the Secretary, which rates may not exceed the daily equivalent for grade GS–18 of the General Schedule for each day (including traveltime) 5 USC 5332 note. they are so engaged; and while so serving away from their homes or regular places of business each member may be allowed travel expenses, including per diem in lieu of subsistence, as authorized by section 5703 of title 5 of the United States Code for persons in the Government service employed intermittently. The Secretary shall Chairman. designate the chairman of an advisory committee from its members. The Secretary shall furnish each advisory committee with clerical and other assistance, and shall by regulation prescribe the procedures to be followed by each such committee in acting on referrals made under subparagraph (A). “(C) The Secretary shall make public the report and recommendation Information, availability to public. made by an advisory committee with respect to an application and shall by order, stating the reasons therefor, either affirm the order referred to the advisory committee or reverse such order and, if appropriate, approve or deny approval of the application, reinstate the application’s approval, approve the protocol, or place in effect a notice of completion, “Service, of Orders “(h) Orders of the Secretary under this section shall be served (1) in person by any officer or employee of the department designated by the Secretary, or (2) by mailing the order by registered mail or certified mail addressed to the applicant at his last known address in the records of the Secretary. “banned devices “Sec. 516. “General Rule (a) Whenever the Secretary finds, on the basis of all available data and information and after consultation with the Ante, p. 540. appropriate panel or panels under section 513, that— “(1) a device intended for human use presents substantial deception or an unreasonable and substantial risk of illness or injury; and “(2) in the case of substantial deception or an unreasonable and substantial risk of illness or injury which the Secretary determined could be corrected or eliminated by labeling or change in labeling and with respect to which the Secretary provided written notice to the manufacturer specifying the deception or risk of illness or injury, the labeling or change in labeling to correct the deception or eliminate or reduce such risk, and the period within which such labeling or change in labeling was to be done, such labeling or change in labeling was not done within such period; he may initiate a proceeding to promulgate a regulation to make such Hearing. device a banned device. The Secretary shall afford all interested persons opportunity for an informal hearing on a regulation proposed under this subsection. “Special Effective Date “(b) The Secretary may declare a proposed regulation under subsection (a) to be effective upon its publication in the Federal Register and until the effective date of any final action taken respecting such regulation if (1) he determines, on the basis of all available data and information, that the deception or risk of illness or injury associated with the use of the device which is subject to the regulation presents an unreasonable, direct, and substan rial danger to the health of individuals, and (2) before the date of the publication of such regulation, the Secretary notifies the manufacturer of such device that such Notice and hearing. regulation is to be made so effective. If the Secretary makes a proposed regulation so effective, he shall, as expeditiously as possible, give interested persons prompt notice of his action under this subsection, provide reasonable opportunity for an informal hearing on the proposed regulation, and either affirm, modify, or revoke such proposed regulation. “judicial review “Sec. 517. “Application of Section (a) Not later than thirty days after— “(1) the promulgation of a regulation under section 513 classifying a device in class I or changing the classification of a device to class I or an order under subsection (f) (2) of such section reclassifying a device or denying a petition for reclassification of a device, “(2) the promulgation of a regulation under section 514 establishing, amending, or revoking a performance standard for a device, “(3) the issuance of an order under section 514(b) (2) or 515 Ante, p. 552. (b) (2) (B) denying a request for reclassification of a device, “(4) the promulgation of a regulation under paragraph (3) of section 515(b) requiring a device to have an approval of a pre-market application, a regulation under paragraph (4) of that section amending or revoking a regulation under paragraph (3), or an order pursuant to section 515(g)(1) or 515 (g) (2) (C), Ante, p. 552. Ante, p. 560. “(5) the promulgation of a regulation under section 516 (other than a proposed regulation made effective under subsection (b) of such section upon the regulation’s publication) making a device a banned device, “(6) the issuance of an order under section 520(f) (2), or Post, p. 565. “(7) an order under section 520(g) (4) disapproving an application for an exemption of a device for investigational use or an order under section 520(g)(5) withdrawing such an exemption for a device, any person adversely affected by such regulation or order may file a petition with the United States Court of Appeals for the District of Columbia or for the circuit wherein such person resides or has his principal place of business for judicial review of such regulation or order. A copy of the petition shall be transmitted by the clerk of the court to the Secretary or other officer designated by him for that purpose. The Secretary shall file in the court the record of the proceedings on which the Secretary based his regulation or order as provided m section 2112 of title 28, United States Code. For purposes of this section, “Record.” the term ‘record’ means all notices and other matter published in the Federal Register with respect to the regulation or order reviewed, all information submitted to the Secretary with respect to such regulation or order, proceedings of any panel or advisory committee with respect to such regulation or order, any hearing held with respect to such regulation or order, and any other information identified by the Secretary, in the administrative proceeding held with respect to such regulation or order, as being relevant to such regulation or order. “Additional Data, Views, and Arguments “(b) If the petitioner applies to the court for leave to adduce additional data, views, or arguments respecting the regulation or order being reviewed and shows to the satisfaction of the court that such additional data, views, or arguments are material and that there were reasonable grounds for the petitioner’s failure to adduce such data, views, or arguments in the proceedings before the Secretary, the court may order the Secretary to provide additional opportunity for the oral presentation of data, views, or arguments and for written sub-missions. The Secretary may modify his findings, or make new findings Modifications. by reason of the additional data, views, or arguments sc taken and shall file with the court such modified or new findings, and his recommendation, if any, for the modification or setting aside of the regulation or order being reviewed, with the return of such additional data, view’s, or arguments. “Standard for Review “(c) Upon the filing of the petition tinder subsection (a) of this section for judicial review of a regulation or order, the court shall have jurisdiction to review the regulation or order in accordance with chapter 7 of title 5, United States Code, and to grant appropriate 5 USC 701 et seq. relief, including interim relief, as provided in such chapter. A regulation described in paragraph (2) or (5) of subsection (a) and an order issued after the review provided by section 515(g) shall not be affirmed if it is found to be unsupported by substantial evidence on the record taken as a whole. “Finality of Judgments “(d) The judgment of the court affirming or setting aside, in whole or in part, any regulation or order shall be final, subject to review by the Supreme Court of the United States upon certiorari or certification, as provided in section 1254 of title 28 of the United States Code. “Other Remedies “(e) The remedies provided for in this section shall be in addition to and not in lieu of any other remedies provided by law. “Statement of Reasons “(f) To facilitate judicial review under this section or under any other provision of law of a regulation or order issued under section 513, 514, 515, 516, 518, 519, 520, or 521 each such regulation or order shall contain a statement of the reasons for its issuance and the basis, in the record of the proceedings held in connection with its issuance, for its issuance. “notification and other remedies “Sec. 518. “Notification (a) If the Secretary determines that— “(1) a device intended for human use which is introduced or delivered for introduction into interstate commerce for commercial distribution presents an unreasonable risk of substantial harm to the public health, and “(2) notification under this subsection is necessary to eliminate the unreasonable risk of such harm and no more practicable means is available under the provisions of this Act (other than this section) to eliminate such risk, the Secretary may issue such order as may be necessary to assure that adequate notification is provided in an appropriate form, by the per-sons and means best suited under the circumstances involved, to all health professionals who prescribe or use the device and to any other person (including manufacturers, importers, distributors, retailers, and device users) who should properly receive such notification in order to eliminate such risk. An order under this subsection shall require that the individuals subject to the risk with respect to which the order is to be issued be included in the persons to be notified of the risk unless the Secretary determines that notice to such individuals would present, a greater danger to the health of such individuals than no such notification. If the Secretary makes such a determination with respect to such individuals, the order shall require that the health professionals who prescribe or use the device provide for the notification of the individuals whom the health professionals treated with the device of the risk presented by the device and of any action which may be taken by or on behalf of such individuals to eliminate or reduce such risk. Before issuing an order under this subsection, the Secretary shall consult with the persons who are to give notice under the order. “Repair, Replacement, or Refund “(b) (1) (A) If, after affording opportunity for an informal hearing, the Secretary determines that— “(i) a device intended for human use which is introduced or delivered for introduction into interstate commerce for commer-cial distribution presents an unreasonable risk of substantial harm to the public health, “(ii) there are reasonable grounds to believe that the device was not properly designed and manufactured with reference to the state of the art as it existed at the tune of its design and manufacture, “(iii) there are reasonable grounds to believe that the unreasonable risk was not caused by failure of a person other than a manufacturer, importer, distributor, or retailer of the device to exercise due care in the installation, maintenance, repair, or use of the device, and “(iv) the notification authorized by subsection (a) would not by itself be sufficient to eliminate the unreasonable risk and action described in paragraph (2) of this subsection is necessary to eliminate such risk, the Secretary may order the manufacturer, importer, or any distributor of such device, or any combination of such persons, to submit to him within a reasonable time a plan for taking one or more of the actions described in paragraph (2). An order issued under the preceding sentence which is directed to more than one person shall specify which person may decide which action shall be taken under such plan and the person specified shall be the person who the Secretary determines bears the principal, ultimate financial responsibility for action taken under the plan unless the Secretary cannot determine who bears such responsibility or the Secretary determines that the protection of the public health requires that such decision be made by a person (including a device user or health professional) other than the person he determines bears such responsibility. “(B) The Secretary shall approve a plan submitted pursuant to Hearing. an order issued under subparagraph (A) unless he determines (after affording opportunity for an informal hearing) that the action or actions to be taken under the plan or the manner in which such action or actions are to be taken under the plan will not assure that the unreasonable risk with respect to which such order was issued will be eliminated. If the Secretary disapproves a plan, he shall order a revised plan to be submitted to him within a reasonable time. If the Secretary Hearing. determines (after affording opportunity for an informal hearing) that the revised plan is unsatisfactory or if no revised plan or no initial plan has been submitted to the Secretary within the prescribed time, the Secretary shall (i) prescribe a plan to be carried out by the person or persons to whom the order issued under subparagraph (A) was directed, or (ii) after affording an opportunity for an informal hearing, by order prescribe a plan to be carried out by a person who is a manufacturer, importer, distributor, or retailer of the device with respect to which the order was issued but to whom the order under subparagraph (A) was not directed. “(2) The actions which may be taken under a plan submitted under an order issued under paragraph (1) arc as follows: “(A) To repair the device so that it does not present the unreasonable risk of substantial harm with respect to which the order under paragraph (1) was issued. “(B) To replace the device with a like or equivalent device which is in conformity with all applicable requirements of this Act. “(C) To refund the purchase price of the device (less a reasonable allowance for use if such device has been in the possession of the device user for one year or more— “(i) at the time of notification ordered under subsection (a),or “(ii) at th© time the device user receives actual notice of the unreasonable risk with respect to which the order was issued under paragraph (1), whichever first occurs). “(3) No charge shall be made to any person (other than a manufacturer, importer, distributor or retailer) for availing himself of any remedy, described in paragraph (2) and provided under an order issued under paragraph (1), and the person subject to the order shall reimburse each person (other than a manufacturer, importer, distributor, or retailer) who is entitled to such a remedy for any reasonable and foreseeable expenses actually incurred by such person in availing himself of such remedy. “Reimbursement “(c) An order issued under subsection (b) with respect to a device may require any person who is a manufacturer, importer, distributor, or retailer of the device to reimburse any other person who is a manufacturer, importer, distributor, or retailer of such device for such other person’s expenses actually incurred in connection with carrying out the order if the Secretary determines such reimbursement is required for the protection of the public health. Any such requirement shall not affect, any rights or obligations under any contract to which the person receiving reimbursement or the person making such reimbursement is a party. “Effect on Other Liability “(d) Compliance with an order issued under this section shall not relieve any person from liability under Federal or State law. In awarding damages for economic loss in an action brought for the enforcement of any such liability, the value to the plaintiff in such action of any remedy provided him under such order shall be taken into account. “records and reports on devices “Sec. 519. “General Rule (a) Every person who is a manufacturer, importer, or distributor of a device intended for human use shall establish and maintain such records, make such reports, and provide such information, as the Secretary may by regulation reasonably require to assure that such device is not adulterated or misbranded and to otherwise assure its safety and effectiveness. Regulations prescribed under the preceding sentence— “(1) shall not impose requirements unduly burdensome to a device manufacturer, importer, or distributor taking into account his cost of complying with such requirements and the need for the protection of the public health and the implementation of this Act.; “(2) which prescribe the procedure for making requests for reports or information shall require that each request made under such regulations for submission of a report or information to the Secretary state the reason or purpose for such request and identify to the fullest extent practicable such report or information; “(3) which require submission of a report or information to the Secretary shall state the reason or purpose for the submission of such report or information and identify to the fullest extent practicable such report or information; “(4) may not require that the identity of any patient be dis-closed in records, reports, or information required under this subsection unless required for the medical welfare of an individual, to determine the safety or effectiveness of a device, or to verify a record, report, or information submitted under this Act; and “(5) may not require a manufacturer, importer, or distributor of a class I device to— “(A) maintain for such a device records respecting information not in the possession of the manufacturer, importer, or distributor, or “(B) to submit for such a device to the Secretary any report or information— “(i) not in the possession of the manufacturer, importer, or distributor, or “(ii) on a periodic basis, unless such report or information is necessary to determine if the device should be reclassified or if the device is adulterated or misbranded. In prescribing such regulations, the Secretary shall have due regard for the professional ethics of the medical profession and the interests of patients. The prohibitions of paragraph (4) of this subsection continue to apply to records, reports, and information concerning any individual who has been a patient, irrespective of whether or when he ceases to be a patient. “Persons Exempt “(b) Subsection (a) shall not apply to— “(1) any practitioner who is licensed by law to prescribe or administer devices intended for use in humans and who manufactures or imports devices solely for use in the course of his professional practice : “(2) any person who manufactures or imports devices intended for use in humans solely for such person’s use in research or teaching and not for sale (including any person who uses a device under an exemption granted under section 520(g)); and Infra. “(3) any other class of persons as the Secretary may by regulation exempt from subsection (a) upon a finding that compliance with the requirements of such sunsection by such class with respect to a device is not necessary to ( A ) assure that a device is not adulterated or misbranded or (B) otherwise to assure its safety and effectiveness. “general provisions respecting control of devices intended for human use “Sec. 520. “General Rule (a) Any requirement authorized by or under section 501, 21 USC 360j. 21 USC 351, 352, 360. 502, 510, or 519 applicable to a device intended for human use shall apply to such device until the applicability of the requirement to the device has been changed by action taken under section 513, 514, or 515 Ante. p. 564. Ante, pu. 540, 546, 552. or under subsection (g) of this section, and any requirement established by or under section 501, 502, 510, or 519 which is inconsistent with a requirement imposed on such device under section 514 or 515 or under subsection (g) of this section shall not apply to such device. “Custom Devices “(b) Sections 514 and 515 do not apply to any device which, in order to comply with the order of an individual physician or dentist (or any other specially qualified person designated under regulations promulgated by the Secretary after an opportunity for an oral hearing) necessarily deviates from an otherwise applicable performance standard or requirement prescribed by or under section 515 if (1) the device is not generally available in finished form for purchase or for dispensing upon prescription and is not offered through labeling or advertising by the manufacturer, importer, or distributor thereof for commercial distribution, and (2) such device— “(A) (i) is intended for use by an individual patient named in such order of such physician or dentist (or other specially qualified person so designated) and is to be made in a specific form for such patient, or “(ii) is intended to meet the special needs of such physician or dentist (or other specially qualified person so designated) in the course of the professional practice of such physician or dentist (or other specially qualified person so designated), and “(B) is not generally available to or generally used by other physicians or dentists (or other specially qualified persons so designated). “Trade Secrets “(c) Any information reported to or otherwise obtained by the Secretary or his representative under section 513, 514, 515. 516, 518, 519, Ante, pp. 540, 546, 552, 560, 562, 564. 21 USC 374. or 704 or under subsection (f) or (g) of this section which is exempt from disclosure pursuant to subsection (a) of section 552 of title 5, United States Code, by reason of subsection (b) (4) of such section shall be considered confidential and shall not be disclosed and may not be used by the Secretary as the basis for the reclassification of a device under section 513 from class III to class II or as the basis for the establishment or amendment of a performance standard under section 514 for a device reclassified from class III to class II, except that such information may be disclosed to other officers or employees concerned with carrying out this Act or when relevant in any proceeding under this Act (other than section 513 or 514 thereof). “Notices and Findings “(d) Each notice of proposed rulemaking under section 513,514,515, 516, 518, or 519, or under this section, any other notice which is published in the Federal Register with respect to any other action taken under any such section and which states the reasons for such action, and each publication of findings required to be made in connection with rulemaking under any such section shall set forth— “(1) the manner in which interested persons may examine data and other information on which the notice or findings is based, and “(2) the period within which interested persons may present their comments on the notice or findings (including the need therefor) orally or in writing, which period shall be at least sixty days but may not exceed ninety days unless the time is extended by the Secretary by a notice published in the Federal Register stating good cause therefor. “Restricted Devices “(e) (1) The Secretary may by regulation require that a device be Regulation. restricted to sale, distribution, or use— “(A) only upon the written or oral authorization of a practitioner licensed by law to administer or use such device, or “(B) upon such other conditions as the Secretary may prescribe in such regulation, if, because of its potentiality for harmful effect or the collateral measures necessary to its use, the Secretary determines that there cannot otherwise be reasonable assurance of its safety and effectiveness. No condition prescribed under subparagraph (B) may restrict the use of a device to persons with specific training or experience in its use or to persons for use in certain facilities unless the Secretary determines that such a restriction is required for the safe and effective use of the device. No such condition may exclude a person from using a device solely because the person does not have the training or experience to make him eligible for certification by a certifying board recognized by the American Board of Medical Specialties or has not been certified by such a Board. A device subject to a regulation under this subsection is a restricted device. “(2) The label of a restricted device shall bear such appropriate Labeling. statements of the restrictions required by a regulation under paragraph (1) as the Secretary may in such regulation prescribe. “Good Manufacturing Practice Requirements “(f) (1) (A) The Secretary may, in accordance with subparagraph Regulations. (B), prescribe regulations requiring that the methods used in, and the facilities and controls used for, the manufacture, packing, storage, and installation of a device conform to current good manufacturing practice, as prescribed in such regulations, to assure that the device will be safe and effective and otherwise in compliance with this Act. “(B) Before the Secretary may promulgate any regulation under subparagraph (A) he shall— “(i) afford the advisory committee established under paragraph Recommendations. (3) an opportunity to submit recommendations to him with respect to the regulation proposed to be promulgated, and “(ii) afford opportunity for an oral hearing. Hearing. The Secretary shall provide the advisory committee a reasonable time to make its recommendation with respect to proposed regulations under subparagraph (A). “(2) (A) Any person subject to any requirement prescribed by regulations Petition for exemption or variance. under paragraph (1) may petition the Secretary for an exemption or variance from such requirement. Such a petition shall be submitted to the Secretary in such form and manner as he shall prescribe and shall— “(i) in the case of a petition for an exemption from a requirement, set forth the basis for the petitioner’s determination that compliance with the requirement is not required to assure that the device will be safe and effective and otherwise in compliance with this Act, “(ii) in the case of a petition for a variance from a requirement, set forth the methods proposed to be used in, and the facilities and controls proposed to lie used for, the manufacture, packing, storage, and installation of the device in lieu of the methods, facilities, and controls prescribed by the requirement, and “(iii) contain such other information as the Secretary shall prescribe. “(B) The Secretary may refer to the advisory committee established under paragraph (3) any petition submitted under subparagraph Recommendations. (A). The advisory committee shall report its recommendations to the Secretary with respect to a petition referred to it within sixty days of the date of the petition’s referral. Within sixty days after— “(i) the date the petition was submitted to the Secretary under subparagraph (A), or “(ii) if the petition was referred to an advisory committee, the expiration of the sixty-day period beginning on the date the petition was referred to the advisory committee, ever occurs later, the Secretary shall by order either deny the petition or approve it. “(C) The Secretary may approve— “(i) a petition for an exemption for a device from a requirement if he determines that compliance with such requirement is not required to assure that the device will be safe and effective and otherwise in compliance with this Act, and “(ii) a petition for a variance for a device from a requirement if he determines that the methods to be used in, and the facilities and controls to be used for, the manufacture, packing, storage, and installation of the device in lieu of the methods, controls, and facilities prescribed by the requirement are sufficient to assure that the device will be safe and effective and otherwise in compliance with tills Act. An order of the Secretary approving a petition for a variance shall prescribe such conditions respecting the methods used in, and the facilities and controls used for, the manufacture, packing, storage, and installation of the device to be granted the variance under the petition as may be necessary to assure that the device will be safe and effective and otherwise in compliance with this Act. “(D) After the issuance of an order under subparagraph (B) respecting a petition, the petitioner shall have an opportunity for an informal hearing on such order. “(3) The Secretary shall establish an advisory committee for the purpose of advising and making recommendations to him with respect to regulations proposed to be promulgated under paragraph (1) (A) and the approval or disapproval of petitions submitted under Membership. paragraph (2). The advisory committee shall lie composed of nine members as follows: “(A) Three of the members shall be appointed from persons who are officers or employees of any State or local government or of the Federal Government. “(B) Two of the members shall be appointed from persons who are representative of interests of the device manufacturing industry; two of the members shall be appointed from persons who are representative of the interests of physicians and other health professionals; and two of the members shall be representative of the interests of the general public. Members of the advisory committee who are not officers or employees of the United States, while attending conferences or meetings of the committee or otherwise engaged in its business, shall be entitled to receive compensation at rates to be fixed by the Secretary, which rates may not exceed the daily equivalent of the rate in effect for grade 5 USC 5332 note. GS–18 of the General Schedule, for each day (including traveltime) they are so engaged; and while so serving away from their homes or regular places of business each member may be allowed travel expenses, including per diem in lieu of subsistence, as authorized by section 5703 of title 5 of the United States Code for persons in the Government service employed intermittently. The Secretary shall designate one of the members of the advisory committee to serve as its chairman. The Secretary shall furnish the advisory committee with clerical and other assistance. Section 14 of the Federal Advisory Committee Act 5 USC app. 1. shall not apply with respect to the duration of the advisory committee established under this paragraph. “Exemption for Devices for Investigational Use “(g) (1) It is the purpose of this subsection to encourage, to the extent consistent with the protection of the public health and safety and with ethical standards, the discovery and development of useful devices intended for human use and to that end to maintain optimum freedom for scientific investigators in their pursuit of that purpose. “(2) (A) The Secretary shall, within the one hundred and twenty-day Regulation. period beginning on the date of the enactment of this section, by regulation prescribe procedures and conditions under which devices intended for human use may upon application be granted an exemption from the requirements of section 502, 510, 514, 515, 516, 519, or 706 or subsection (e) or (f) of this section or from any combination 21 USC 352, 360. Ante, pp. 546, 552, 560, 564. 21 USC 376. of such requirements to permit the investigational use of such devices by experts qualified by scientific training and experience to investigate the safety and effectiveness of such devices. “(B) The conditions prescribed pursuant to subparagraph (A) shall include the following: “(i) A requirement that an application be submitted to the Secretary before an exemption may be granted and that the application be submitted in such form and manner as the Secretary shall specify. “(ii) A requirement that the person applying for an exemption for a device assure the establishment and maintenance of such records, and the making of such reports to the Secretary of data obtained as a result of the investigational use of the device during the exemption, as the Secretary determines will enable him to assure compliance with such conditions, review the progress of the investigation, and evaluate the safety and effectiveness of the device. “(iii) Such other requirements as the Secretary may determine to be necessary for the protection of the public health and safety. “(C) Procedures and conditions prescribed pursuant to subparagraph (A) for an exemption may appropriately vary depending on (i) the scope and duration of clinical testing to be conducted under such exemption, (ii) the number of human subjects that are to be involved in such testing, (iii) the need to permit changes to be made in the device subject to the exemption during testing conducted in accordance with a clinical testing plan required under paragraph (3) (A), and (iv) whether the clinical testing of such device is for the purpose of developing data to obtain approval for the commercial distribution of such device. “(3) Procedures and conditions prescribed pursuant to paragraph (2) (A) shall require, as a condition to the exemption of any device to be the subject of testing involving human subjects, that the person applying for the exemption— “(A) submit a plan for any proposed clinical testing of the device and a report of prior investigations of the device (includ-trig, where appropriate, tests on animals) adequate to justify the proposed clinical testing— “(i) to the local institutional review committee which has been established in accordance with regulations of the Secretary to supervise clinical testing of devices in the facilities where the proposed clinical testing is to be conducted, or “(ii) to the Secretary, if— “(I) no such committee exists, or “(II) the Secretary finds that the process of review by such committee is inadequate (whether or not the plan for such testing has been approved by such committee), for review for adequacy to justify the commencement of such testing; and, unless the plan and report are submitted to the Secretary, submit to the Secretary a summary of the plan and a report of prior investigations of the device (including, where appropriate, tests on animals); “(B) promptly notify the Secretary (under such circumstances and in such manner as the Secretary prescribes) of approval by a local institutional review committee of any clinical testing plan submitted to it in accordance with subparagraph (A); “(C) in the case of a device to be distributed to investigators for testing, obtain signed agreements from each of such investigators that any testing of the device involving human subjects will be under such investigator’s supervision and in accordance with subparagraph (D) and submit such agreements to the Secretary; and “(D) assure that informed consent will be obtained from each human subject (or his representative) of proposed clinical testing involving such device, except where subject to such conditions as the Secretary may prescribe, the investigator conducting or supervising the proposed clinical testing of the device determines in writing that there exists a life threatening situation involving the human subject of such testing which necessitates the use of such device and it is not feasible to obtain informed consent from the subject and there is not sufficient time to obtain such consent from his representative. The determination required by subparagraph (D) shall be concurred in by a licensed physician who is not involved in the testing of the human subject with respect to which such determination is made unless immediate use of the device is required to save the life of the human subject of such testing and there is not sufficient time to obtain such concurrence. “(4) (A) An application, submitted in accordance with the procedures prescribed by regulations under paragraph (2), for an exemption for a device (other than an exemption from section 516) shall be deemed approved on the thirtieth day after the submission of the application to the Secretary unless on or before such day the Secretary by order disapproves the application and notifies the applicant of the disapproval of the application. “(B) The Secretary may disapprove an application only if he finds that the investigation with respect to which the application is submitted does not conform to procedures and conditions prescribed under Hearing. regulations under paragraph (2). Such a notification shall contain the order of disapproval and a complete statement of the reasons for the Secretary’s disapproval of the application and afford the applicant opportunity for an informal hearing on the disapproval order. “(5) The Secretary may by order withdraw an exemption granted under this subsection for a device if the Secretary determines that the conditions applicable to the device under this subsection for such exemption are not met. Such an order may be issued only after opportunity for an informal hearing, except that such an order may be issued before the provision of an opportunity for an informal hearing if the Secretary determines that the continuation of testing under the exemption with respect to which the order is to be issued will result in an unreasonable risk to the public health. “Release of Safety and Effectiveness Information “(h) (1) The Secretary shall promulgate regulations under which Regulations. a detailed summary of information respecting the safety and effectiveness of a device which information was submitted to the Secretary and which was the basis for— “(A) an order under section 515(d)(1)(A) approving an Ante, p. 552. application for premarket approval for the device or denying approval of such an application or an order under section 515(e) withdrawing approval of such an application for the device, “(B) an order under section 515(f)(6)(A) revoking an approved protocol for the device, an order under section 515(f) (6)(B) declaring a protocol for the device completed or not completed, or an order under section 515(f)(7) revoking the approval of the device, or “(C) an order approving an application under subsection (g) for an exemption for the device from section 516 or an order disapproving, or withdrawing approval of, an application for an exemption under such subsection for the device, shall be made available to the public upon issuance of the order. Ante, p. 560. Summaries of information made available pursuant to this paragraph respecting a device shall include information respecting any adverse effects on health of the device. “(2) The Secretary shall promulgate regulations under which each Regulations. advisory committee established under section 515(g)(2)(B) shall make available to the public a detailed summary of information respecting the safety and effectiveness of a device which information was submitted to the advisory committee and which was the basis for its recommendation to the Secretary made pursuant to section 515 (g) (2) (A). A summary of information upon which such a recommendation is based shall be made available pursuant to this paragraph only after the issuance of the order with respect to which the recommendation was made and each summary shall include information respecting any adverse effect on health of the device subject to such order. “(3) Any information respecting a device which is made available pursuant to paragraph (1) or (2) of this subsection (A) may not be used to establish the safety or effectiveness of another device for purposes of this Act by any person other than the person who submitted the information so made available, and (B) shall be made available subject to subsection (c) of this section. “Proceedings of Advisory Panels and Committees “(i) Each panel under section 513 and each advisory committee Ante, p. 540. Ante, p. 546. established under section 514(g) (5) (B) or 515(g) or under subsection (f) of this section shall make and maintain a transcript of any proceeding of the panel or committee, Each such panel and committee shall delete from any transcript made pursuant to this subsection information which under subsection (c) of this section is to be considered confidential. “Traceability Requirements “(j) No regulation under this Act may impose on a type or class of device requirements for the traceability of such type or class of device unless such requirements are necessary to assure the protection of the public health. “Research and Development “(k) The Secretary may enter into contracts for research, testing, and demonstrations respecting devices and may obtain devices for research, testing, and demonstration purposes without regard to sections 3648 and 3709 of the Revised Statutes (31 U.S.C. 529, 41 U.S.C. 5). “Transitional Provisions for Devices Considered as New Drugs or Antibiotic Drugs “(l) (1) Any device intended for human use— “(A) for which on the date of enactment of the Medical Device Amendments of 1976 (hereinafter in this subsection referred to as the ‘enactment date’) an approval of an application 21 USC 355. submitted under section 505 (b) was in effect; “(B) for which such an application was filed on or before the enactment date and with respect to which application no order of approval or refusing to approve had been issued on such date under subsection (c) or (d) of such section; “(C) for which on the enactment date an exemption under subsection (i) of such section was in effect; “(D) which is within a type of device described in subparaSraph (A), (B), or (C) and is substantially equivalent to another device within that type; “(E) which the Secretary in a notice published in the Federal Register before the enactment date has declared to be a new drug subject to section 505; or “(F) with respect to which on the enactment date an action is pending in a United States court under section 302, 303, or 304 for an alleged violation of a provision of section 301 which enforces a requirement of section 505 or for an alleged violation of section 505(a), is classified in class III unless the Secretary in response to a petition submitted under paragraph (2) has classified such device in class I or II. “(2) The manufacturer or importer of a device classified under paragraph (1) may petition the Secretary (in such form and manner as he shall prescribe) for the issuance of an order classifying the Notification. device in class I or class II. Within thirty days of the filing of such a petition, the Secretary shall notify the petitioner of any deficiencies in the petition which prevent the Secretary from making a decision Hearing. on the petition. Except as provided in paragraph (3) (D) (ii), within one hundred and eighty days after the filing of a petition under this paragraph and after affording the petitioner an opportunity for an informal hearing, the Secretary shall, after consultation with the Ante, p. 540. appropriate panel under section 513, by order either deny the petition or order the classification, in accordance with the criteria prescribed by section 513(a) (1) (A) or 513(a) (1) (B), of the device in class I or class II. “(3) (A) In the case of a device which is described in paragraph (1) (A) and which is in class III— “(i) such device shall on the enactment date be considered a device with an approved application under section 515, and Ante, p. 552. “(ii) the requirements applicable to such device before the enactment date under section 505 shall continue to apply to such 21 USC 355. device until changed by the Secretary as authorized by this Act. “(B) Tn the case of a device which is described in paragraph (1) (B) and which is in class III, an application for such device shall be considered as having been filed under section 515 on the enactment date. The period in which the Secretary shall act on such application in accordance with section 515(d) (1) shall be one hundred and eighty days from the enactment date (or such greater period as the Secretary and the applicant may agree upon after the Secretary has made the finding required by section 515 (d) (1) (B) (i)) less the number of days in the period beginning on the date an application for such device was filed under section 505 and ending on the enactment date. After the expiration of such period such device is required, unless exempt under subsection (g), to have in effect an approved application under section 515. “(C) A device which is described in paragraph (1) (C) and which is in class TH shall be considered a new drug until the expiration of the ninety-day period beginning on the date of the promulgation of regulations under subsection (g) of this section. After the expiration of such period such device is required, unless exempt under subsection (g), to have in effect an approved application under section 515. “(D) (i) Except as provided in clauses (ii) and (iii), a device which is described in subparagraph (D), (E), or (F) of paragraph (1) and which is in class III is required, unless exempt under subsection (g) of this section, to have on and after sixty days after the enactment date in effect an approved application under section 515. “(ii) If— “(I) a petition is filed under paragraph (2) for a device described in subparagraph (D), (E),or (F) of paragraph (1),or “(II) an application for premarket approval is filed under section 515 for such a device, within the sixty-day period beginning on the enactment date (or within such greater period as the Secretary, after making the finding required under section 515(d)(1)(B), and the petitioner or applicant may agree upon), the Secretary shall act on such petition or application in accordance with paragraph (2) or section 515 except that the period within which the Secretary must act on the petition or application shall be within the one hundred and twenty-day period beginning on the date the petition or application is filed. If such a petition or application is filed within such sixty-day (or greater) period, clause (i) of this subparagraph shall not apply to such device before the expiration of such one hundred and twenty-day period, or if such petition is denied or such application is denied approval, before the date of such denial, whichever occurs first. “(iii) In the case of a device which is described in subparagraph Publication in Federal Register. (E) of paragraph (1), which the Secretary in a notice published in the Federal Register after March 31, 1976, declared to be a new drug subject to section 505, and which is in class TIT— “(I) the device shall, after eighteen months after the enactment date, have in effect an approved application under section 515 unless exempt under subsection (g) of this section, and “(II) the Secretary may, during the period beginning one hundred and eighty days after the enactment date and ending eighteen months after such date, restrict the use of the device to investigational use by experts qualified by scientific training and experience to investigate the safety and effectiveness of such device, and to investigational use in accordance with the requirements applicable muter regulations under subsection (g) of this section to investigational use of devices granted an exemption under such subsection. If the requirements under subsection (g) of this section are made applicable to the investigational use of such a device, they shall be made applicable in such a manner that the device shall be made reasonably available, to physicians meeting appropriate qualifications prescribed by the Secretary. “(4) Any device intended for human use which on the enactment date was subject to the requirements of section 507 shall be subject to such requirements as follows: “(A) In the case of such a device which is classified into class I, such requirements shall apply to such device until the effective date of the regulation classifying the device into such class. “(B) In the case of such a device which is classified into class II, such requirements shall apply to such device until the effective date of a performance standard applicable to the device under Ante, p. 546. section 514. “(C) In the case of such a device which is classified into class III, such requirements shall apply to such device until the date on which the device is required to have in effect an approved Ante, p. 552. application under section 515. “state and local requirements respecting devices “Sec. 521. “General Rule (a) Except as provided in subsection (b), no State or political subdivision of a State may establish or continue in effect with respect to a device intended for human use any requirement— “(1) which is different from, or in addition to, any requirement applicable under this Act to the device, and “(2) which relates to the safety or effectiveness of the device or to any other matter included in a requirement applicable to the device under this Act. “Exempt Requirements “(b) Upon application of a State or a political subdivision thereof, the Secretary may, by regulation promulgated after notice and opportunity for an oral hearing, exempt from subsection (a), under such conditions as may be prescribed in such regulation, a requirement of such State or political subdivision applicable to a device intended for human use if— “(1) the requirement is more stringent than a requirement under this Act which would be applicable to the device if an exemption were not in effect under this subsection; or “(2) the requirement— “(A) is required by compelling local conditions, and “(B) compliance with the requirement would not cause the device to be in violation of any applicable requirement under this Act.”.

2. 1990

   Pub. L. 101–629 § 18(c) · 104 Stat. 4469

   1. Substituted · 21 U.S.C. § 360e(c)(2)

      Pub. L. 101–629, § 18(c), substituted “the Secretary—” for “the Secretary shall”

   2. Added · 21 U.S.C. § 360e(c)(2)

      Pub. L. 101–629, § 18(c), added subpars. (A) and (B)

   Source evidence

   Code amendment note
   Subsec. (c)(2). Pub. L. 101–629, § 18(c), substituted “the Secretary—” for “the Secretary shall” and added subpars. (A) and (B).

   Enacted provision · exact public law section
   (c) Section515.— Section 515(c)(2) (21 U.S.C. 360e(c)(2)) is amended by striking out “paragraph (1), the Secretary shall refer such application” and inserting in lieu thereof “paragraph (1), the Secretary— “(A) may on the Secretary’s own initiative refer such application, or “(B) shall, upon the request of an applicant unless the Secretary finds that the information in the application which would be reviewed by a panel substantially duplicates information which has previously been reviewed by a panel appointed under section 513. refer such application”.

3. 1990

   Pub. L. 101–629 § 9(a)(2) · 104 Stat. 4469

   Inserted · 21 U.S.C. § 360e(e)

   Pub. L. 101–629, § 9(a)(2), inserted “and temporary suspension” after “Withdrawal” in heading

   Source evidence

   Code amendment note
   Subsec. (e). Pub. L. 101–629, § 9(a)(2), inserted “and temporary suspension” after “Withdrawal” in heading.

   Enacted provision · exact public law section
   (2) in the subsection heading, by inserting “and Temporary Suspension” after “Withdrawal”.

4. 1990

   Pub. L. 101–629 § 9(a)(1) · 104 Stat. 4469

   Added · 21 U.S.C. § 360e(e)(3)

   Pub. L. 101–629, § 9(a)(1), added par. (3)

   Source evidence

   Code amendment note
   Subsec. (e)(3). Pub. L. 101–629, § 9(a)(1), added par. (3).

   Enacted provision · exact public law section
   (1) by adding at the end the following: “(3) If, after providing an opportunity for an informal hearing, the Secretary determines there is reasonable probability that the continuation of distribution of a device under an approved application would cause serious, adverse health consequences or death, the Secretary shall by order temporarily suspend the approval of the application approved under this section. If the Secretary issues such an order, the Secretary shall proceed expeditiously under paragraph (1) to withdraw such application.”, and

5. 1990

   Pub. L. 101–629 § 4(b)(1) · 104 Stat. 4469

   Added · 21 U.S.C. § 360e(i)

   Pub. L. 101–629, § 4(b)(1), added subsec. (i)

   Source evidence

   Code amendment note
   Subsec. (i). Pub. L. 101–629, § 4(b)(1), added subsec. (i).

   Enacted provision · exact public law section
   (1) Section 515 (21 U.S.C. 360e) is amended by adding at the end the following: “(i) “Revision (1) Before December 1, 1995, the Secretary shall by order require manufacturers of devices, which were introduced or delivered for introduction into interstate commerce for commercial dis-tribution before May 28, 1976, and which are subject to revision of classification under paragraph (2), to submit to the Secretary a summary of and citation to any information known or otherwise available to the manufacturer respecting such devices, including adverse safety or effectiveness information which has not been submitted under section 519. The Secretary may require the manufacturer to submit the adverse safety or effectiveness data for which a summary and citation were submitted, if such data are available to the manufacturer. “(2) After the issuance of an order under paragraph (1) but before Regulations. Federal Register, publication. December 1, 1995, the Secretary shall publish a regulation in the Federal Register for each device— “(A) which the Secretary has classified as a class III device, and “(B) for which no final regulation has been promulgated under section 515(b), revising the classification of the device so that the device is classified into class I or class II, unless the regulation requires the device to remain in class III. In determining whether to revise the classification of a device or to require a device to remain in class III, the Regulations. Secretary shall apply the criteria set forth in section 513(a). Before the publication of a regulation requiring a device to remain in class III or revising its classification, the Secretary shall publish a pro-posed regulation respecting the classification of a device under this paragraph and provide reasonable opportunity for the submission of comments on any such regulation. No regulation requiring a device to remain in class III or revising its classification may take effect before the expiration of 90 days from the date of its publication in the Federal Register as a proposed regulation. “(3) The Secretary shall, as promptly as is reasonably achievable, but not later than 12 months after the effective date of the regulation requiring a device to remain in class III, establish a schedule for the promulgation of a section 515(b) regulation for each device which is subject to the regulation requiring the device to remain in class III.”.

6. 1993

   Nutrition Labeling and Education Act Amendments of 1993

   Pub. L. 103–80 § 3(t) · 107 Stat. 773

   Struck · 21 U.S.C. § 360e(c)(2)(A)

   Pub. L. 103–80 struck out “refer such application” after “own initiative”

   Source evidence

   Code amendment note
   Subsec. (c)(2)(A). Pub. L. 103–80 struck out “refer such application” after “own initiative”.

   Enacted provision · exact public law section
   (t) Section 515.— Section 515(c)(2)(A) (21 U.S.C. 360e(c)(2)(A)) is amended by striking out “refer such application”.

7. 1997

   Food and Drug Administration Modernization Act of 1997

   Pub. L. 105–115 § 205(c)(1) · 111 Stat. 2296

   Inserted · 21 U.S.C. § 360e(d)(1)(A)

   Pub. L. 105–115, § 205(c)(1), inserted at end “In making the determination whether to approve or deny the application, the Secretary shall rely on the conditions of use included in the proposed labeling as the basis for determining whether or not there is a reasonable assurance of safety and effectiveness, if the proposed labeling is neither false nor misleading. In determining whether or not such labeling is false or misleading, the Secretary shall fairly evaluate all material facts pertinent to the proposed labeling.”

   Source evidence

   Code amendment note
   Subsec. (d)(1)(A). Pub. L. 105–115, § 205(c)(1), inserted at end “In making the determination whether to approve or deny the application, the Secretary shall rely on the conditions of use included in the proposed labeling as the basis for determining whether or not there is a reasonable assurance of safety and effectiveness, if the proposed labeling is neither false nor misleading. In determining whether or not such labeling is false or misleading, the Secretary shall fairly evaluate all material facts pertinent to the proposed labeling.”

   Enacted provision · exact public law section
   (1) in paragraph (1)(A), by adding after and below clause (ii) the following: “In making the determination whether to approve or deny the application, the Secretary shall rely on the conditions of use included in the proposed labeling as the basis for determining whether or not there is a reasonable assurance of safety and effectiveness, if the proposed labeling is neither false nor misleading. In determining whether or not such labeling is false or misleading, the Secretary shall fairly evaluate all material facts pertinent to the proposed labeling”; and

8. 1997

   Food and Drug Administration Modernization Act of 1997

   Pub. L. 105–115 § 201(b) · 111 Stat. 2296

   Added · 21 U.S.C. § 360e(d)(1)(B)(iii)

   Pub. L. 105–115, § 201(b), added cl. (iii)

   Source evidence

   Code amendment note
   Subsec. (d)(1)(B)(iii). Pub. L. 105–115, § 201(b), added cl. (iii).

   Enacted provision · exact public law section
   (b) Action on Application.— Section 515(d)(1)(B) (21 U.S.C. 360e(d)(1)(B)) is amended by adding at the end the following: “(iii) The Secretary shall accept and review statistically valid and reliable data and any other information from investigations conducted under the authority of regulations required by section 520(g) to make a determination of whether there is a reasonable assurance of safety and effectiveness of a device subject to a pending application under this section if— “(I) the data or information is derived from investigations of an earlier version of the device, the device has been modified during or after the investigations (but prior to submission of an application under subsection (c)) and such a modification of the device does not constitute a significant change in the design or in the basic principles of operation of the device that would invalidate the data or information; or “(II) the data or information relates to a device approved under this section, is available for use under this Act, and is relevant to the design and intended use of the device for which the application is pending.”.

9. 1997

   Food and Drug Administration Modernization Act of 1997

   Pub. L. 105–115 § 202(1) · 111 Stat. 2296

   1. Added · 21 U.S.C. § 360e(d)(3); 21 U.S.C. § 360e(d)(4)

      Pub. L. 105–115, § 202(1), 209(b), added par. (3)

   2. Redesignated · 21 U.S.C. § 360e(d)(3); 21 U.S.C. § 360e(d)(4)

      Pub. L. 105–115, § 202(1), 209(b), redesignated former par. (3) as (4)

   Source evidence

   Code amendment note
   Subsec. (d)(3), (4). Pub. L. 105–115, § 202(1), 209(b), added par. (3) and redesignated former par. (3) as (4).

   Enacted provision · exact public law section
   (1) by redesignating paragraph (3) as paragraph (4); and

10. 1997

    Food and Drug Administration Modernization Act of 1997

    Pub. L. 105–115 § 202(2) · 111 Stat. 2296

    Added · 21 U.S.C. § 360e(d)(5)

    Pub. L. 105–115, § 202(2), added par. (5)

    Source evidence

    Code amendment note
    Subsec. (d)(5). Pub. L. 105–115, § 202(2), added par. (5).

    Enacted provision · exact public law section
    (2) by adding at the end the following: “(5) In order to provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions, the Secretary shall provide review priority for devices— “(A) representing breakthrough technologies, “(B) for which no approved alternatives exist, “(C) which offer significant advantages over existing approved alternatives, or “(D) the availability of which is in the best interest of the patients.”.

11. 1997

    Food and Drug Administration Modernization Act of 1997

    Pub. L. 105–115 § 205(c)(2) · 111 Stat. 2296

    Added · 21 U.S.C. § 360e(d)(6)

    Pub. L. 105–115, § 205(c)(2), added par. (6)

    Source evidence

    Code amendment note
    Subsec. (d)(6). Pub. L. 105–115, § 205(c)(2), added par. (6).

    Enacted provision · exact public law section
    (2) by adding after paragraph (5) (as added by section 202(2)) the following: “(6) (A) (i) A supplemental application shall be required for any change to a device subject to an approved application under this subsection that affects safety or effectiveness, unless such change is a modification in a manufacturing procedure or method of manufacturing and the holder of the approved application submits a written notice to the Secretary that describes in detail the change, summarizes the data or information supporting the change, and informs the Secretary that the change has been made under the requirements of section 520(f). “(ii) The holder of an approved application who submits a notice under clause (i) with respect to a manufacturing change of a device may distribute the device 30 days after the date on which the Secretary receives the notice, unless the Secretary within such 30-day period notifies the holder that the notice is not adequate and describes such further information or action that is required for acceptance of such change. If the Secretary notifies the holder that a supplemental application is required, the Secretary shall review the supplement within 135 days after the receipt of the supplement. The time used by the Secretary to review the notice of the manufacturing change shall be deducted from the 135-day review period if the notice meets appropriate content requirements for premarket approval supplements. “(B) (i) Subject to clause (ii), in reviewing a supplement to an approved application, for an incremental change to the design of a device that affects safety or effectiveness, the Secretary shall approve such supplement if— “(I) nonclinical data demonstrate that the design modification creates the intended additional capacity, function, or performance of the device; and “(II) clinical data from the approved application and any supplement to the approved application provide a reasonable assurance of safety and effectiveness for the changed device. “(ii) The Secretary may require, when necessary, additional clinical data to evaluate the design modification of the device to provide a reasonable assurance of safety and effectiveness”.

12. 1997

    Food and Drug Administration Modernization Act of 1997

    Pub. L. 105–115 § 216(b) · 111 Stat. 2296

    Substituted · 21 U.S.C. § 360e(f)(2)

    Pub. L. 105–115, § 216(b), substituted “the Secretary—” and subpars. (A) and (B) for “he shall refer the proposed protocol to the appropriate panel under section 360c of this title for its recommendation respecting approval of the protocol.”

    Source evidence

    Code amendment note
    Subsec. (f)(2). Pub. L. 105–115, § 216(b), substituted “the Secretary—” and subpars. (A) and (B) for “he shall refer the proposed protocol to the appropriate panel under section 360c of this title for its recommendation respecting approval of the protocol.”

    Enacted provision · exact public law section
    (b) Product Development Protocol.— Section 515(f)(2) (21 U.S.C. 360e(f)(2)) is amended by striking “he shall” and all that follows and inserting the following: “the Secretary— “(A) may, at the initiative of the Secretary, refer the proposed protocol to the appropriate panel under section 513 for its recommendation respecting approval of the protocol; or “(B) shall so refer such protocol upon the request of the submitter, unless the Secretary finds that the proposed protocol and accompanying data which would be reviewed by such panel substantially duplicate a product development protocol and accompanying data which have previously been reviewed by such a panel.”.

13. 2002

    Medical Device User Fee and Modernization Act of 2002

    Pub. L. 107–250 § 302(c)(1) · 116 Stat. 1588

    Inserted · 21 U.S.C. § 360e(a)

    Pub. L. 107–250, § 302(c)(1), inserted “or, as applicable, an approval under subsection (c)(2) of a report seeking premarket approval” before period in concluding provisions

    Source evidence

    Code amendment note
    Subsec. (a). Pub. L. 107–250, § 302(c)(1), inserted “or, as applicable, an approval under subsection (c)(2) of a report seeking premarket approval” before period in concluding provisions.

    Enacted provision · exact public law section
    (1) in subsection (a), in the matter after and below paragraph (2), by inserting before the period the following: “or, as applicable, an approval under subsection (c)(2) of a report seeking premarket approval”; and

14. 2002

    Medical Device User Fee and Modernization Act of 2002

    Pub. L. 107–250 § 302(c)(2)(B) · 116 Stat. 1588

    Redesignated · 21 U.S.C. § 360e(c)(2)

    Pub. L. 107–250, § 302(c)(2)(B), added par. (2). Former par. (2) redesignated (3)

    Source evidence

    Code amendment note
    Subsec. (c)(2). Pub. L. 107–250, § 302(c)(2)(B), added par. (2). Former par. (2) redesignated (3).

    Enacted provision · exact public law section
    (B) by inserting after paragraph (1) the following paragraph: “(2) (A) Any person may file with the Secretary a report seeking premarket approval for a class III device referred to in subsection (a) that is a reprocessed single-use device. Such a report shall contain the following: “(i) The device name, including both the trade or proprietary name and the common or usual name. “(ii) The establishment registration number of the owner or operator submitting the report. “(iii) Actions taken to comply with performance standards under section 514. “(iv) Proposed labels, labeling, and advertising sufficient to describe the device, its intended use, and directions for use. “(v) Full reports of all information, published or known to or which should be reasonably known to the applicant, concerning investigations which have been made to show whether or not the device is safe or effective. “(vi) A description of the device’s components, ingredients, and properties. “(vii) A full description of the methods used in, and the facilities and controls used for, the reprocessing and packing of the device. “(viii) Such samples of the device that the Secretary may reasonably require. “(ix) A financial certification or disclosure statement or both, as required by part 54 of title 21, Code of Federal Regulations. “(x) A statement that the applicant believes to the best of the applicant’s knowledge that all data and information submitted to the Secretary are truthful and accurate and that no material fact has been omitted in the report. “(xi) Any additional data and information, including information of the type required in paragraph (1) for an application under such paragraph, that the Secretary determines is necessary to determine whether there is reasonable assurance of safety and effectiveness for the reprocessed device. “(xii) Validation data described in section 510(o)(1)(A) that demonstrates that the reasonable assurance of the safety or effectiveness of the device will remain after the maximum number of times the device is reprocessed as intended by the person submitting such report. “(B) In the case of a class III device referred to in subsection (a) that is a reprocessed single-use device: “(i) Subparagraph (A) of this paragraph applies in lieu of paragraph (1). “(ii) Subject to clause (i), the provisions of this section apply to a report under subparagraph (A) to the same extent and in the same manner as such provisions apply to an application under paragraph (1). “(iii) Each reference in other sections of this Act to an application under this section, other than such a reference in section 737 or 738, shall be considered to be a reference to a report under subparagraph (A). “(iv) Each reference in other sections of this Act to a device for which an application under this section has been approved, or has been denied, suspended, or withdrawn, other than such a reference in section 737 or 738, shall be considered to be a reference to a device for which a report under subparagraph (A) has been approved, or has been denied, suspended, or withdrawn, respectively.”.

15. 2002

    Medical Device User Fee and Modernization Act of 2002

    Pub. L. 107–250 § 302(c)(2)(A) · 116 Stat. 1588

    Redesignated · 21 U.S.C. § 360e(c)(3)

    Pub. L. 107–250, § 302(c)(2)(A), redesignated par. (2) relating to Secretary’s referral of application to appropriate panel as (3)

    Source evidence

    Code amendment note
    Subsec. (c)(3). Pub. L. 107–250, § 302(c)(2)(A), redesignated par. (2) relating to Secretary’s referral of application to appropriate panel as (3).

    Enacted provision · exact public law section
    (A) by redesignating paragraph (2) as paragraph (3); and

16. 2002

    Medical Device User Fee and Modernization Act of 2002

    Pub. L. 107–250 § 210 · 116 Stat. 1588

    1. Amended · 21 U.S.C. § 360e(c)(3)

       Pub. L. 107–250, § 210, as amended by Pub. L. 108–214, § 2(d)(1)(B)

    2. Redesignated · 21 U.S.C. § 360e(c)(3)

       Pub. L. 107–250, § 210, as inserted “Where appropriate, the Secretary shall ensure that such panel includes, or consults with, one or more pediatric experts.” at the end of the concluding provisions of par. (3) as redesignated by Pub. L. 107–250, § 302(c)(2)(A)

    Target inherited from the preceding amendment note.

    Source evidence

    Code amendment note
    Pub. L. 107–250, § 210, as amended by Pub. L. 108–214, § 2(d)(1)(B), inserted “Where appropriate, the Secretary shall ensure that such panel includes, or consults with, one or more pediatric experts.” at the end of the concluding provisions of par. (3) as redesignated by Pub. L. 107–250, § 302(c)(2)(A).

    Enacted provision · exact public law section
    SEC. 210. PEDIATRIC EXPERTISE REGARDING CLASSIFICATION-PANEL REVIEW OF PREMARKET APPLICATIONS. Section 515(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(c)), as amended by section 302(c)(2)(A) of this Act, is amended in paragraph (3) by adding at the end the following: “Where appropriate, the Secretary shall ensure that such panel includes, or consults with, one or more pediatric experts.”.

17. 2002

    Medical Device User Fee and Modernization Act of 2002

    Pub. L. 107–250 § 209 · 116 Stat. 1588

    Added · 21 U.S.C. § 360e(c)(3)

    Pub. L. 107–250, § 209, added par. (3) relating to acceptance and review of any portion of the application prior to submission

    Target inherited from the preceding amendment note.

    Source evidence

    Code amendment note
    Pub. L. 107–250, § 209, added par. (3) relating to acceptance and review of any portion of the application prior to submission.

    Enacted provision · exact public law section
    SEC. 209. MODULAR REVIEW. Section 515(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(c)) is amended by adding at the end the following: “(3) (A) Prior to the submission of an application under this subsection, the Secretary shall accept and review any portion of the application that the applicant and the Secretary agree is complete, ready, and appropriate for review, except that such requirement does not apply, and the Secretary has discretion whether to accept and review such portion, during any period in which, under section 738(g), the Secretary does not have the authority to collect fees under section 738(a). “(B) Each portion of a submission reviewed under subparagraph (A) and found acceptable by the Secretary shall not be further reviewed after receipt of an application that satisfies the requirements of paragraph (1), unless an issue of safety or effectiveness provides the Secretary reason to review such accepted portion. “(C) Whenever the Secretary determines that a portion of a submission under subparagraph (A) is unacceptable, the Secretary shall, in writing, provide to the applicant a description of any deficiencies in such portion and identify the information that is required to correct these deficiencies, unless the applicant is no longer pursuing the application.”.

18. 2004

    Medical Devices Technical Corrections Act

    Pub. L. 108–214 § 2(d)(1)(B) · 118 Stat. 572

    Amended · 21 U.S.C. § 360e(c)(3)

    Pub. L. 108–214, § 2(d)(1)(B), amended directory language of Pub. L. 107–250, § 210. See 2002 Amendment note below

    Source evidence

    Code amendment note
    Subsec. (c)(3). Pub. L. 108–214, § 2(d)(1)(B), amended directory language of Pub. L. 107–250, § 210. See 2002 Amendment note below.

    Enacted provision · exact public law section
    (B) Conforming amendment.— Section 210 of Public Law 107–250 (116 Stat. 1614) 21 USC 360e. is amended by striking “, as amended” and all that follows through “by adding” and inserting “is amended in paragraph (3), as redesignated by section 302(c)(2)(A) of this Act, by adding”.

19. 2004

    Medical Devices Technical Corrections Act

    Pub. L. 108–214 § 2(d)(1)(A)(i) · 118 Stat. 572

    Redesignated · 21 U.S.C. § 360e(c)(3)

    Pub. L. 108–214, § 2(d)(1)(A)(i), redesignated par. (3) relating to acceptance and review of any portion of the application prior to submission as (4)

    Target inherited from the preceding amendment note.

    Source evidence

    Code amendment note
    Pub. L. 108–214, § 2(d)(1)(A)(i), redesignated par. (3) relating to acceptance and review of any portion of the application prior to submission as (4).

    Enacted provision · exact public law section
    (i) Technical correction.— Section 515(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(c)), as amended by sections 209 and 302(c)(2)(A) of Public Law 107–250 (116 Stat. 1613, 1618), is amended by redesignating paragraph (3) (as added by section 209 of such Public Law) as paragraph (4).

20. 2004

    Medical Devices Technical Corrections Act

    Pub. L. 108–214 § 2(d)(1)(A) · 118 Stat. 572

    1. Redesignated · 21 U.S.C. § 360e(c)(4)

       Pub. L. 108–214, § 2(d)(1)(A), redesignated par. (3) relating to acceptance and review of any portion of the application prior to submission as (4)

    2. Substituted · 21 U.S.C. § 360e(c)(4)

       Pub. L. 108–214, § 2(d)(1)(A), substituted “unless a significant issue of safety” for “unless an issue of safety” in subpar. (B)

    Source evidence

    Code amendment note
    Subsec. (c)(4). Pub. L. 108–214, § 2(d)(1)(A), redesignated par. (3) relating to acceptance and review of any portion of the application prior to submission as (4) and substituted “unless a significant issue of safety” for “unless an issue of safety” in subpar. (B).

    Enacted provision · exact public law section
    (A) In general.— (i) Technical correction.— Section 515(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(c)), as amended by sections 209 and 302(c)(2)(A) of Public Law 107–250 (116 Stat. 1613, 1618), is amended by redesignating paragraph (3) (as added by section 209 of such Public Law) as paragraph (4). (ii) Modular review.— Section 515(c)(4)(B) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(c)(4)(B)) is amended by striking “unless an issue of safety” and inserting “unless a significant issue of safety”.

21. 2007

    Food and Drug Administration Amendments Act of 2007

    Pub. L. 110–85 title VIII § 801(b)(3)(D) · 121 Stat. 823

    1. Added · 21 U.S.C. § 360e(c)(1)(G); 21 U.S.C. § 360e(c)(1)(H)

       Pub. L. 110–85 added subpar. (G)

    2. Redesignated · 21 U.S.C. § 360e(c)(1)(G); 21 U.S.C. § 360e(c)(1)(H)

       Pub. L. 110–85 redesignated former subpar. (G) as (H)

    Source evidence

    Code amendment note
    Subsec. (c)(1)(G), (H). Pub. L. 110–85 added subpar. (G) and redesignated former subpar. (G) as (H).

    Enacted provision · exact public law section
    (D) Device premarket approval application.— Section 515(c)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(c)(1)) is amended— (i) in subparagraph (F), by striking “; and” and inserting a semicolon; (ii) by redesignating subparagraph (G) as subparagraph (H); and (iii) by inserting after subparagraph (F) the following: “(G) the certification required under section 402(j)(5)(B) of the Public Health Service Act (which shall not be considered an element of such application); and” .

22. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(A) · 126 Stat. 993

    Substituted · 21 U.S.C. § 360e(a)(1)

    Pub. L. 112–144, § 608(b)(1)(A), substituted “an order issued under subsection (b) (or a regulation promulgated under such subsection prior to July 9, 2012)” for “regulation promulgated under subsection (b)”

    Source evidence

    Code amendment note
    Subsec. (a)(1). Pub. L. 112–144, § 608(b)(1)(A), substituted “an order issued under subsection (b) (or a regulation promulgated under such subsection prior to July 9, 2012)” for “regulation promulgated under subsection (b)”.

    Enacted provision · exact public law section
    (A) in subsection (a), by striking “regulation promulgated under subsection (b)” and inserting “an order issued under subsection (b) (or a regulation promulgated under such subsection prior to the date of enactment of the Food and Drug Administration Safety and Innovation Act)”;

23. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(B)(i)(I) · 126 Stat. 993

    Substituted · 21 U.S.C. § 360e(b)

    Pub. L. 112–144, § 608(b)(1)(B)(i)(I), which directed substitution of “Order” for “Regulation” in the heading of par. (1) of subsec. (b), was executed by making the substitution in the heading of subsec. (b), to reflect the probable intent of Congress

    Source evidence

    Code amendment note
    Subsec. (b). Pub. L. 112–144, § 608(b)(1)(B)(i)(I), which directed substitution of “Order” for “Regulation” in the heading of par. (1) of subsec. (b), was executed by making the substitution in the heading of subsec. (b), to reflect the probable intent of Congress.

    Enacted provision · exact public law section
    (I) in the heading, by striking “Regulation” and inserting “Order”; and

24. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(B)(i)(II) · 126 Stat. 993

    1. Substituted · 21 U.S.C. § 360e(b)(1)

       Pub. L. 112–144, § 608(b)(1)(B)(i)(II), in concluding provisions, substituted “by administrative order following publication of a proposed order in the Federal Register, a meeting of a device classification panel described in section 360c(b) of this title, and consideration of comments from all affected stakeholders, including patients, payors, and providers, notwithstanding subchapter II of chapter 5 of title 5” for “by regulation, promulgated in accordance with this subsection”

    2. Inserted · 21 U.S.C. § 360e(b)(1)

       Pub. L. 112–144, § 608(b)(1)(B)(i)(II), in concluding provisions, inserted at end “Authority to issue such administrative order shall not be delegated below the Director of the Center for Devices and Radiological Health, acting in consultation with the Commissioner.”

    Source evidence

    Code amendment note
    Subsec. (b)(1). Pub. L. 112–144, § 608(b)(1)(B)(i)(II), in concluding provisions, substituted “by administrative order following publication of a proposed order in the Federal Register, a meeting of a device classification panel described in section 360c(b) of this title, and consideration of comments from all affected stakeholders, including patients, payors, and providers, notwithstanding subchapter II of chapter 5 of title 5” for “by regulation, promulgated in accordance with this subsection” and inserted at end “Authority to issue such administrative order shall not be delegated below the Director of the Center for Devices and Radiological Health, acting in consultation with the Commissioner.”

    Enacted provision · exact public law section
    (II) in the matter following subparagraph (B)— (aa) by striking “by regulation, promulgated in accordance with this subsection” and inserting “by administrative order following publication of a proposed order in the Federal Register, a meeting of a device classification panel described in section 513(b), and consideration of comments from all affected stakeholders, including patients, payors, and providers, notwithstanding subchapter II of chapter 5 of title 5, United States Code”; and (bb) by adding at the end the following: “Authority to issue such administrative order shall not be delegated below the Director of the Center for Devices and Radiological Health, acting in consultation with the Commissioner.”;

25. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(B)(ii) · 126 Stat. 993

    1. Struck · 21 U.S.C. § 360e(b)(2)

       Pub. L. 112–144, § 608(b)(1)(B)(ii), struck out subpar. (A) designation after “(2)”

    2. Substituted · 21 U.S.C. § 360e(b)(2)

       Pub. L. 112–144, § 608(b)(1)(B)(ii), substituted “A proposed order required under paragraph (1) shall contain—” for “A proceeding for the promulgation of a regulation under paragraph (1) respecting a device shall be initiated by the publication in the Federal Register of a notice of proposed rulemaking. Such notice shall contain—” in introductory provisions

    3. Redesignated · 21 U.S.C. § 360e(b)(2)

       Pub. L. 112–144, § 608(b)(1)(B)(ii), redesignated cls. (i) to (iv) as subpars. (A) to (D), respectively

    4. Substituted · 21 U.S.C. § 360e(b)(2)

       Pub. L. 112–144, § 608(b)(1)(B)(ii), substituted “order” for “regulation” in subpars. (A) and (C)

    5. Struck · 21 U.S.C. § 360e(b)(2)

       Pub. L. 112–144, § 608(b)(1)(B)(ii), struck out former subpar. (B) which read as follows: “If, within fifteen days after publication of a notice under subparagraph (A), the Secretary receives a request for a change in the classification of a device, he shall, within sixty days of the publication of such notice and after consultation with the appropriate panel under section 360c of this title, by order published in the Federal Register, either deny the request for change in classification or give notice of his intent to initiate such a change under section 360c(e) of this title.”

    Source evidence

    Code amendment note
    Subsec. (b)(2). Pub. L. 112–144, § 608(b)(1)(B)(ii), struck out subpar. (A) designation after “(2)” and substituted “A proposed order required under paragraph (1) shall contain—” for “A proceeding for the promulgation of a regulation under paragraph (1) respecting a device shall be initiated by the publication in the Federal Register of a notice of proposed rulemaking. Such notice shall contain—” in introductory provisions, redesignated cls. (i) to (iv) as subpars. (A) to (D), respectively, substituted “order” for “regulation” in subpars. (A) and (C), and struck out former subpar. (B) which read as follows: “If, within fifteen days after publication of a notice under subparagraph (A), the Secretary receives a request for a change in the classification of a device, he shall, within sixty days of the publication of such notice and after consultation with the appropriate panel under section 360c of this title, by order published in the Federal Register, either deny the request for change in classification or give notice of his intent to initiate such a change under section 360c(e) of this title.”

    Enacted provision · exact public law section
    (ii) in paragraph (2)— (I) by striking subparagraph (B); and (II) in subparagraph (A)— (aa) by striking “(2)(A) A proceeding for the promulgation of a regulation under paragraph (1) respecting a device shall be initiated by the publication in the Federal Register of a notice of proposed rulemaking. Such notice shall contain—” and inserting “(2) A proposed order required under paragraph (1) shall contain—”; (bb) by redesignating clauses (i) through (iv) as subparagraphs (A) through (D), respectively; (cc) in subparagraph (A), as so redesignated, by striking “regulation” and inserting “order”; and (dd) in subparagraph (C), as so redesignated, by striking “regulation” and inserting “order”;

26. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(B)(iii)(I) · 126 Stat. 993

    1. Substituted · 21 U.S.C. § 360e(b)(3)

       Pub. L. 112–144, § 608(b)(1)(B)(iii)(I), (II), (IV), (V), substituted “proposed order” for “proposed regulation”

    2. Substituted · 21 U.S.C. § 360e(b)(3)

       Pub. L. 112–144, § 608(b)(1)(B)(iii)(I), (II), (IV), (V), substituted “paragraph (2),” for “paragraph (2) and after”

    3. Substituted · 21 U.S.C. § 360e(b)(3)

       Pub. L. 112–144, § 608(b)(1)(B)(iii)(I), (II), (IV), (V), substituted “(A) issue an administrative order under paragraph (1)” for “(A) promulgate such regulation”

    4. Substituted · 21 U.S.C. § 360e(b)(3)

       Pub. L. 112–144, § 608(b)(1)(B)(iii)(I), (II), (IV), (V), substituted “paragraph (2)(B)” for “paragraph (2)(A)(ii)”

    5. Substituted · 21 U.S.C. § 360e(b)(3)

       Pub. L. 112–144, § 608(b)(1)(B)(iii)(I), (II), (IV), (V), substituted “issuance of the administrative order” for “promulgation of the regulation”

    Source evidence

    Code amendment note
    Subsec. (b)(3). Pub. L. 112–144, § 608(b)(1)(B)(iii)(I), (II), (IV), (V), substituted “proposed order” for “proposed regulation” in two places, “paragraph (2),” for “paragraph (2) and after”, “(A) issue an administrative order under paragraph (1)” for “(A) promulgate such regulation”, “paragraph (2)(B)” for “paragraph (2)(A)(ii)”, and “issuance of the administrative order” for “promulgation of the regulation”.

    Enacted provision · exact public law section
    (I) by striking “proposed regulation” each place such term appears and inserting “proposed order”;

27. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(B)(iii)(III) · 126 Stat. 993

    Inserted · 21 U.S.C. § 360e(b)(3)

    Pub. L. 112–144, § 608(b)(1)(B)(iii)(III), which directed insertion of “and a meeting of a device classification panel described in section 360c(b) of this title,” after “such proposed regulation and findings,” was inserted after “such proposed order and findings,” to reflect the probable intent of Congress and amendment by Pub. L. 112–144, § 608(b)(1)(B)(iii)(I). See above

    Target inherited from the preceding amendment note.

    Source evidence

    Code amendment note
    Pub. L. 112–144, § 608(b)(1)(B)(iii)(III), which directed insertion of “and a meeting of a device classification panel described in section 360c(b) of this title,” after “such proposed regulation and findings,” was inserted after “such proposed order and findings,” to reflect the probable intent of Congress and amendment by Pub. L. 112–144, § 608(b)(1)(B)(iii)(I). See above.

    Enacted provision · exact public law section
    (III) by inserting “and a meeting of a device classification panel described in section 513(b),” after “such proposed regulation and findings,”;

28. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(B)(iv) · 126 Stat. 993

    Struck · 21 U.S.C. § 360e(b)(4)

    Pub. L. 112–144, § 608(b)(1)(B)(iv), struck out par. (4) which read as follows: “The Secretary, upon his own initiative or upon petition of an interested person, may by regulation amend or revoke any regulation promulgated under this subsection. A regulation to amend or revoke a regulation under this subsection shall be promulgated in accordance with the requirements prescribed by this subsection for the promulgation of the regulation to be amended or revoked.”

    Source evidence

    Code amendment note
    Subsec. (b)(4). Pub. L. 112–144, § 608(b)(1)(B)(iv), struck out par. (4) which read as follows: “The Secretary, upon his own initiative or upon petition of an interested person, may by regulation amend or revoke any regulation promulgated under this subsection. A regulation to amend or revoke a regulation under this subsection shall be promulgated in accordance with the requirements prescribed by this subsection for the promulgation of the regulation to be amended or revoked.”

    Enacted provision · exact public law section
    (iv) by striking paragraph (4); and

29. 2012

    Medical Device User Fee Amendments of 2012

    Pub. L. 112–144 § 203(g) · 126 Stat. 993

    Substituted · 21 U.S.C. § 360e(c)(4)(A)

    Pub. L. 112–144, § 203(g), substituted “379j(h)” for “379j(g)”

    Source evidence

    Code amendment note
    Subsec. (c)(4)(A). Pub. L. 112–144, § 203(g), substituted “379j(h)” for “379j(g)”.

    Enacted provision · exact public law section
    (g) Conforming Amendment.— Section 515(c)(4)(A) (21 U.S.C. 360e(c)(4)(A)) is amended by striking “738(g)” and inserting “738(h)”.

30. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(C)(i)(III) · 126 Stat. 993

    1. Substituted · 21 U.S.C. § 360e(i)(2)

       Pub. L. 112–144, § 608(b)(1)(C)(i)(III), (IV), in concluding provisions, substituted “administrative order issued under this paragraph requires” for “regulation requires”

    2. Struck · 21 U.S.C. § 360e(i)(2)

       Pub. L. 112–144, § 608(b)(1)(C)(i)(III), (IV), in concluding provisions, struck out at end “Before the publication of a regulation requiring a device to remain in class III or revising its classification, the Secretary shall publish a proposed regulation respecting the classification of a device under this paragraph and provide reasonable opportunity for the submission of comments on any such regulation. No regulation requiring a device to remain in class III or revising its classification may take effect before the expiration of 90 days from the date of its publication in the Federal Register as a proposed regulation.”

    Source evidence

    Code amendment note
    Subsec. (i)(2). Pub. L. 112–144, § 608(b)(1)(C)(i)(III), (IV), in concluding provisions, substituted “administrative order issued under this paragraph requires” for “regulation requires” and struck out at end “Before the publication of a regulation requiring a device to remain in class III or revising its classification, the Secretary shall publish a proposed regulation respecting the classification of a device under this paragraph and provide reasonable opportunity for the submission of comments on any such regulation. No regulation requiring a device to remain in class III or revising its classification may take effect before the expiration of 90 days from the date of its publication in the Federal Register as a proposed regulation.”

    Enacted provision · exact public law section
    (III) in the matter following subparagraph (B), by striking “regulation requires” and inserting “administrative order issued under this paragraph requires”; and

31. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(C)(i)(I) · 126 Stat. 993

    1. Substituted · 21 U.S.C. § 360e(i)(2)

       Pub. L. 112–144, § 608(b)(1)(C)(i)(I), in introductory provisions, substituted “the date that is 2 years after July 9, 2012” for “December 1, 1995”

    2. Substituted · 21 U.S.C. § 360e(i)(2)

       Pub. L. 112–144, § 608(b)(1)(C)(i)(I), in introductory provisions, substituted “issue an administrative order following publication of a proposed order in the Federal Register, a meeting of a device classification panel described in section 360c(b) of this title, and consideration of comments from all affected stakeholders, including patients, payors, and providers, notwithstanding subchapter II of chapter 5 of title 5,” for “publish a regulation in the Federal Register”

    Target inherited from the preceding amendment note.

    Source evidence

    Code amendment note
    Pub. L. 112–144, § 608(b)(1)(C)(i)(I), in introductory provisions, substituted “the date that is 2 years after July 9, 2012” for “December 1, 1995” and “issue an administrative order following publication of a proposed order in the Federal Register, a meeting of a device classification panel described in section 360c(b) of this title, and consideration of comments from all affected stakeholders, including patients, payors, and providers, notwithstanding subchapter II of chapter 5 of title 5,” for “publish a regulation in the Federal Register”.

    Enacted provision · exact public law section
    (I) in the matter preceding subparagraph (A)— (aa) by striking “December 1, 1995” and inserting “the date that is 2 years after the date of enactment of the Food and Drug Administration Safety and Innovation Act”; and (bb) by striking “publish a regulation in the Federal Register” and inserting “issue an administrative order following publication of a proposed order in the Federal Register, a meeting of a device classification panel described in section 513(b), and consideration of comments from all affected stakeholders, including patients, payors, and providers, notwithstanding subchapter II of chapter 5 of title 5, United States Code,”;

32. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(C)(i)(II) · 126 Stat. 993

    Substituted · 21 U.S.C. § 360e(i)(2)(B)

    Pub. L. 112–144, § 608(b)(1)(C)(i)(II), substituted “administrative order has been issued under subsection (b) (or no regulation has been promulgated under such subsection prior to July 9, 2012)” for “final regulation has been promulgated under subsection (b) of this section”

    Source evidence

    Code amendment note
    Subsec. (i)(2)(B). Pub. L. 112–144, § 608(b)(1)(C)(i)(II), substituted “administrative order has been issued under subsection (b) (or no regulation has been promulgated under such subsection prior to July 9, 2012)” for “final regulation has been promulgated under subsection (b) of this section”.

    Enacted provision · exact public law section
    (II) in subparagraph (B), by striking “final regulation has been promulgated under section 515(b)” and inserting “administrative order has been issued under subsection (b) (or no regulation has been promulgated under such subsection prior to the date of enactment of the Food and Drug Administration Safety and Innovation Act)”;

33. 2012

    Food and Drug Administration Safety and Innovation Act

    Pub. L. 112–144 § 608(b)(1)(C)(ii) · 126 Stat. 993

    1. Substituted · 21 U.S.C. § 360e(i)(3)

       Pub. L. 112–144, § 608(b)(1)(C)(ii), substituted “order requiring” for “regulation requiring”

    2. Substituted · 21 U.S.C. § 360e(i)(3)

       Pub. L. 112–144, § 608(b)(1)(C)(ii), substituted “issuance of an administrative order under subsection (b)” for “promulgation of a subsection (b) of this section regulation”

    Source evidence

    Code amendment note
    Subsec. (i)(3). Pub. L. 112–144, § 608(b)(1)(C)(ii), substituted “order requiring” for “regulation requiring” in two places and “issuance of an administrative order under subsection (b)” for “promulgation of a subsection (b) of this section regulation”.

    Enacted provision · exact public law section
    (ii) in paragraph (3)— (I) by striking “regulation requiring” each place such term appears and inserting “order requiring”; and (II) by striking “promulgation of a section 515(b) regulation” and inserting “issuance of an administrative order under subsection (b)”.

34. 2016

    21st Century Cures Act

    Pub. L. 114–255 § 3101(a)(2)(J) · 130 Stat. 1033

    Substituted · 21 U.S.C. § 360e(a)(1)

    Pub. L. 114–255, § 3101(a)(2)(J), substituted “subject to an order” for “subject to a an order”

    Source evidence

    Code amendment note
    Subsec. (a)(1). Pub. L. 114–255, § 3101(a)(2)(J), substituted “subject to an order” for “subject to a an order”.

    Enacted provision · exact public law section
    (J) Premarket approval.— Section 515(a)(1) (21 U.S.C. 360e(a)(1)) is amended by striking “subject to a an order” and inserting “subject to an order”.

35. 2016

    21st Century Cures Act

    Pub. L. 114–255 § 3058(b) · 130 Stat. 1033

    Added · 21 U.S.C. § 360e(c)(5)

    Pub. L. 114–255, § 3058(b), added par. (5)

    Source evidence

    Code amendment note
    Subsec. (c)(5). Pub. L. 114–255, § 3058(b), added par. (5).

    Enacted provision · exact public law section
    (b) Premarket Applications.— Section 515(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(c)) is amended by adding at the end the following: “(5) (A) In requesting additional information with respect to an application under this section, the Secretary shall consider the least burdensome appropriate means necessary to demonstrate a reasonable assurance of device safety and effectiveness. “(B) For purposes of subparagraph (A), the term ‘necessary’ means the minimum required information that would support a determination by the Secretary that an application provides a reasonable assurance of the safety and effectiveness of the device. “(C) For purposes of this paragraph, the Secretary shall consider the role of postmarket information in determining the least burdensome means of demonstrating a reasonable assurance of device safety and effectiveness. “(D) Nothing in this paragraph alters the standards for premarket approval of a device.” .

36. 2016

    21st Century Cures Act

    Pub. L. 114–255 § 3051(c)(1) · 130 Stat. 1033

    1. Redesignated · 21 U.S.C. § 360e(d)(5); 21 U.S.C. § 360e(d)(6)

       Pub. L. 114–255, § 3051(c)(1), redesignated par. (6) as (5)

    2. Struck · 21 U.S.C. § 360e(d)(5); 21 U.S.C. § 360e(d)(6)

       Pub. L. 114–255, § 3051(c)(1), struck out former par. (5) which read as follows: “In order to provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions, the Secretary shall provide review priority for devices—

    Source evidence

    Code amendment note
    Subsec. (d)(5), (6). Pub. L. 114–255, § 3051(c)(1), redesignated par. (6) as (5) and struck out former par. (5) which read as follows: “In order to provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions, the Secretary shall provide review priority for devices—

    “(A) representing breakthrough technologies, “(B) for which no approved alternatives exist, “(C) which offer significant advantages over existing approved alternatives, or “(D) the availability of which is in the best interest of the patients.”

    Enacted provision · exact public law section
    (1) In general.— Section 515(d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(d)) is amended— (A) by striking paragraph (5); and (B) by redesignating paragraph (6) as paragraph (5).

37. 2017

    Medical Device User Fee Amendments of 2017

    Pub. L. 115–52 title II § 203(f)(2)(A) · 131 Stat. 1005

    Substituted · 21 U.S.C. § 360e(c)(4)(A)

    Pub. L. 115–52 substituted “section 379j(g)” for “section 379j(h)”

    Source evidence

    Code amendment note
    Subsec. (c)(4)(A). Pub. L. 115–52 substituted “section 379j(g)” for “section 379j(h)”.

    Enacted provision · exact public law section
    (A) Section 515(c)(4)(A) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(c)(4)(A)) is amended by striking “738(h)” and inserting “738(g)”.

    Effective date note
    Amendment by Pub. L. 115–52 effective Oct. 1, 2017, with fees under subpart 3 of part C of subchapter VII of this chapter to be assessed for all submissions listed in section 379j(a)(2)(A) of this title received on or after Oct. 1, 2017, see section 209 of Pub. L. 115–52, set out as a note under section 379i of this title.

38. 2022

    Food and Drug Omnibus Reform Act of 2022

    Pub. L. 117–328 div. FF title III § 3308(b)(2) · 136 Stat. 4459

    Substituted · 21 U.S.C. § 360e(d)(5)(A)(i)

    Pub. L. 117–328 substituted “Unless the change is consistent with a predetermined change control plan approved under section 360e–4 of this title, a supplemental” for “A supplemental”

    Source evidence

    Code amendment note
    Subsec. (d)(5)(A)(i). Pub. L. 117–328 substituted “Unless the change is consistent with a predetermined change control plan approved under section 360e–4 of this title, a supplemental” for “A supplemental”.

    Enacted provision · exact public law section
    (2) Approved devices.— Section 515(d)(5)(A)(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(d)(5)(A)(i)) is amended by striking “A supplemental” and inserting “Unless the change is consistent with a predetermined change control plan approved under section 515C, a supplemental”.

56 of 56 references resolved to an enrolled provision